Neil D. Gross, M.D., F.A.C.S.

Peer-Reviewed Articles

1. Desai P, Gross ND, Contrera K. Neoadjuvant Chemoimmunotherapy in Resectable Head and Neck Cancers—Is It the Way Forward?. JAMA, 2026. e-Pub 2026.
2. Allen, DZ, Gross, N, Nader, M, Ferrarotto, R, Amit, M, Nagarajan, P, Gidley, PW. Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma. Head and Neck 48(3):837-842, 2026. e-Pub 2026. PMID: 41137728.
3. Frank, SJ, Busse, PM, Lee, JJ, Rosenthal, D, Hernandez, M, Swanson, DM, Garden, AS, Gunn, GB, Patel, SH, Snider, JW, Ma, DJ, Molitoris, JK, Lee, N, Parvathaneni, U, McDonald, MW, Kalman, NS, Lin, A, Mohammed, N, Henson, CE, Hyde, C, Bajaj, GK, Katz, SR, Dagan, R, Morrison, WH, Reddy, JP, Fuller, C, Shah, SJ, Phan, J, Chronowski, G, Mayo, LL, Sturgis, EM, Ferrarotto, R, Zhu, XR, Zhang, X, Wang, L, Hutcheson, KA, El-Naggar, AK, Moreno, AC, Lee, A, Spiotto, MT, Gross, N, Lai, SY, Liao, JJ, Paly, JJ, Liao, Z, Foote, RL, Bates, JE, Chambers, MS, Chun, SG, Kaiser, A, Lester, SC, Lukens, JN, McGee, LA, Neben-Wittich, MA, Nguyen, Q, Routman, DM, Schlembach, PJ, Skinner, H, Soike, MH, Rwigema, JM, Wiederhold, LR, Blanchard, P, Choi, I, Koong, A, Langendijk, H, Mohan, R, Carlson, BJ, Mapps, A, Sarmiento, JG, Teferra, MY, Bosch, WR, Followill, DS, Taylor, PA, Fuentes, SY, Ning, M, Toumazis, I, Wogan, CF, De Gracia, B, Fink, K, Grippin, A, Ma, J, Pettersen, EA, Sareyeldin, RM, Cronin, C, Muise, S, Johnson, M, Pyfferoen, K, Tranby, BN, Leonard, J, Watkin, S, Eggleston, C, Barrow, B, Wolcott, J, Antonio, J, Brand, J, Cleverdon, A, Drake, M, Peters, E, Small, C, Clark, K, Holder, R. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA. The Lancet 407(10524):174-184, 2026. e-Pub 2026. PMID: 41391462.
4. Frank, SJ, Busse, PM, Lee, JJ, Rosenthal, D, Hernandez, M, Swanson, DM, Garden, AS, Gunn, GB, Patel, SH, Snider, JW, Ma, DJ, Molitoris, JK, Lee, N, Parvathaneni, U, McDonald, MW, Kalman, NS, Lin, A, Mohammed, N, Henson, CE, Hyde, C, Bajaj, GK, Katz, SR, Dagan, R, Morrison, WH, Reddy, JP, Fuller, C, Shah, SJ, Phan, J, Chronowski, G, Mayo, LL, Sturgis, EM, Ferrarotto, R, Zhu, XR, Zhang, X, Wang, L, Hutcheson, KA, El-Naggar, AK, Moreno, AC, Lee, A, Spiotto, MT, Gross, N, Lai, SY, Liao, JJ, Paly, JJ, Liao, Z, Foote, RL, Bates, JE, Chambers, MS, Chun, SG, Kaiser, A, Lester, SC, Lukens, JN, McGee, LA, Neben-Wittich, MA, Nguyen, Q, Routman, DM, Schlembach, PJ, Skinner, H, Soike, MH, Rwigema, JM, Wiederhold, LR, Blanchard, P, Choi, I, Koong, A, Langendijk, H, Mohan, R, Carlson, BJ, Mapps, A, Sarmiento, JG, Teferra, MY, Bosch, WR, Followill, DS, Taylor, PA, Fuentes, SY, Ning, M, Toumazis, I, Wogan, CF, De Gracia, B, Fink, K, Grippin, A, Ma, J, Pettersen, EA, Sareyeldin, RM, Cronin, C, Muise, S, Johnson, M, Pyfferoen, K, Tranby, BN, Leonard, J, Watkin, S, Eggleston, C, Barrow, B, Wolcott, J, Antonio, J, Brand, J, Cleverdon, A, Drake, M, Peters, E, Small, C, Clark, K, Holder, R. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA. The Lancet 407(10524):174-184, 2026. e-Pub 2026. PMID: 41391462.
5. Bulbul, Mustafa, de Almeida, John R, Gross, Neil D, Turner, Meghan T. Treatment of P16‐Negative/HPV‐Negative Oropharyngeal Squamous Cell Carcinoma: A Survey of AHNS Membership, 2026. e-Pub 2026.
6. Allen DZ, Gross N, Nader M, Ferrarotto R, Amit M, Nagarajan P, Gidley P. Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma. Head and Neck, 2025. e-Pub 2025.
7. Maniakas A, Wilde DC, Fournier I, Hyde EK, Xu L, Wang JR, Gross ND, Sturgis EM, Banuchi V, Busaidy NL, Cabanillas ME, Iyer P, Dadu R, Waguespack SG, Hu MI, Gunn GB, Kwon M, Ahmed S, Williams MD, Zafereo ME. Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival. Head Neck 48(3):644-649, 2025. e-Pub 2025. PMID: 41059669.
8. Baruch EN, Gleber-Netto FO, Nagarajan P, Rao X, Akhter S, Eichwald T, Xie T, Balood M, Adewale A, Naara S, Sathishkumar HN, Islam S, McCarthy W, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Roversi K, Nikpoor AR, Ahmadi M, Ahmadi A, Harwood C, Leigh I, Gong D, Tallon de Lara P, Tao DL, Davidson TM, Ajami NJ, Futreal A, Rai K, Kochat V, Castillo M, Gunaratne P, Goepfert RP, Hernandez SD, Khushalani NI, Wang J, Watowich SS, Calin GA, Migden MR, Yuan M, Liu N, Ye Y, Hwang WL, Vermeer PD, D'Silva NJ, Bunimovich YL, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo JA, Myers JN, Talbot S, Gross ND, Amit M. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature 646(8084):462-473, 2025. e-Pub 2025. PMID: 40836096.
9. Fournier I, Bandi AV, Hamidi S, Iyer P, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Waguespack SG, Basmaci UN, Williams MD, Mansour M, Monroe MG, Gross ND, Goepfert RP, Perrier ND, Banuchi V, Wang JR, Maniakas A, Zafereo ME. Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer. Head Neck 48(1):237-245, 2025. e-Pub 2025. PMID: 40891104.
10. Yaniv D, Naara S, Netto FOG, Stafford H, Buell J, Chiang E, Shahrukh A, Li S, Nagarajan P, Hanna EY, Gross ND, Amit M. Response-Adapted Oncologic Surgery in Cutaneous Squamous Cell Carcinoma: A Paradigm Shift Following Neoadjuvant Immunotherapy. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 40824417.
11. Burtness, B, Flamand, Y, Quon, H, Weinstein, GS, Mehra, R, Garcia, JJ, Kim, S, O’Malley, BW, Ozer, E, Ikpeazu, C, Koch, W, Gross, N, Bell, R, Patel, MR, Lango, MN, Morris, LG, Smith, RB, Karakla, DW, Richmon, JD, Holsinger, F, Ferris, R. Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx Cancer. Journal of Clinical Oncology 43(23):2559-2565, 2025. e-Pub 2025. PMID: 40493877.
12. Jiang, XL, Rudqvist, N, Jiang, B, Ye, S, He, S, Liang, Q, Dou, J, Williams, MD, Dunn, J, Johnson, JM, Akagi, K, Xiao, W, Liang, S, Elayavalli, S, Sun, B, Parra Cuentas, ER, Ferrarotto, R, Garden, AS, Fuller, C, Reddy, JP, Gross, N, Lango, MN, Leung, CH, Liu, S, Liu, D, Li, M, Lee, JJ, Curran, M, Phan, J, Chen, K, Gillison, M. Depletion of Effector Regulatory T Cells Associates with Major Response to Induction Dual Immune Checkpoint Blockade. Cancer discovery 15(8):1569-1592, 2025. e-Pub 2025. PMID: 40249124.
13. McArdle, E, Bulbul, M, Collins, C, Duvvuri, U, Gross, N, Turner, M. Surgery for the Treatment of HPV-Negative Oropharyngeal Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis. Head and Neck 47(6):1749-1757, 2025. e-Pub 2025. PMID: 39866097.
14. Wang, J, Shen, X, Ma, Q, Yang, L, Zhou, X, Wang, L, Cui, J, Zhang, C, Li, G, Gross, N, Li, S, Huang, R, Zhan, C, Cheng, Z, Wang, K, Tian, J, Yuan, Y, Tao, X. Near-infrared fluorescence imaging with an MET-targeting probe for biopsy site selection in patients with oral potentially malignant disorders. Cell Reports Medicine 6(3), 2025. e-Pub 2025. PMID: 39999837.
15. Esmaeli, B, Fan, J, Goldberg, H, Lu, T, Gross, N, Akhave, NS, Sousa, LG, Ferrarotto, R. Immune checkpoint inhibitors with or without chemotherapy for orbital, conjunctival, and ocular adnexal squamous cell carcinoma. Canadian Journal of Ophthalmology 60(1):e38-e51, 2025. e-Pub 2025. PMID: 39043259.
16. Gross ND. Surgery for the treatment of HPV-negative oropharyngeal squamous cell carcinoma – A systematic review and meta-analysis. Head Neck. e-Pub 2025.
17. Li, C, Xu, C, Guan, R, Jiao, R, Wang, Y, Cui, C, Cao, S, Chang, F, Wei, R, Li, Z, Liu, Z, Gross, N, Li, G, Li, W, Wei, D, Lei, D. Spatial transcriptomics reveal tumor microenvironment and SLCO2A1 correlated with tumor suppression in hypopharyngeal squamous cell carcinoma. International Immunopharmacology 142, 2024. e-Pub 2024. PMID: 39340989.
18. Yang Z, Mansour J, Sun P, Wei P, Dahlstrom KR, Zafereo M, Li G, Gross ND. Impact of pretreatment body mass index on the survival of head and neck cancer patients. Head Neck 46(8):1881-1892, 2024. e-Pub 2024. PMID: 38269627.
19. Bravo, L, Simoes, JF, Cardoso, VR, Adisa, AO, Aguilera, ML, Arnaud, AP, Biccard, B, Calvache, JA, Chernbumroong, S, Elhadi, M, Ghosh, D, Gujjuri, RR, Harrison, E, Ho, MW, Kasivisvanathan, V, Kouli, O, Lederhuber, H, Li, E, Löffler, MW, Isik, A, Marcus, HJ, Martin, J, McLean, KA, Minaya-Bravo, A, Modolo, MM, Nepogodiev, D, Pellino, G, Picciochi, M, Pockney, P, van Ramshorst, GH, Riad, A, Sayyed, R, Sund, M, Gkoutos, G, Bhangu, A, Glasbey, J, Cardoso, VR, Glasbey, J, Simoes, JF, Kadir, B, Omar, O, Revell, E, Bahrami-Hessari, M, Ahmed, WU, Argus, L, Kamal Jomaa, M, Gross, N, Gross, JL, Vartanian, JG, Roland, CL. A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score). The Lancet Digital Health 6(7):e507-e519, 2024. e-Pub 2024. PMID: 38906616.
20. Carlander, AF, Bendtsen, SK, Rasmussen, JH, Jakobsen, KK, Garset-Zamani, M, Grønhøj, C, Friborg, J, Hutcheson, KA, Johnson, FM, Fuller, C, Moreno, AC, Babarinde, T, Gross, N, Myers, JN, von Buchwald, C. Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas. European Journal of Cancer 202, 2024. e-Pub 2024. PMID: 38452723.
21. Niu, Z, Sun, P, Zafereo, M, Liu, H, Wei, P, Wu, J, Gross, N, Shete, S, Wei, Q, Zheng, G, Sikora, AG, Calin, GA, Li, G. TGF-β1 and TGF-βR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation. Cancer Immunology, Immunotherapy 73(5), 2024. e-Pub 2024. PMID: 38554185.
22. Yaniv, D, Seiwert, TY, Margalit, D, Williams, MD, Barbon, CE, Largo, RD, Smith, JA, Gross, N. Neoadjuvant chemotherapy for advanced oral cavity cancer. CA Cancer Journal for Clinicians 74(3):213-223, 2024. e-Pub 2024. PMID: 38329372.
23. Anderson, BJ, Moreno, AC, Qing, Y, Lee, JJ, Johnson, FM, Lango, MN, Barbon, CE, Tripuraneni, L, Sahli, A, Piper, V, Gross, N, Fuller, C, Lai, SY, Myers, JN, Hutcheson, KA. Revisiting Feeding Tube Utilization in Oropharynx Cancer. Otolaryngology - Head and Neck Surgery (United States) 170(5):1319-1330, 2024. e-Pub 2024. PMID: 38353360.
24. Gleber-Netto, FO, Nagarajan, P, Sagiv, O, Pickering, CR, Gross, N, Ning, J, Yeshi, MM, Mitku, Y, Tetzlaff, M, Esmaeli, B. Histologic and Genomic Analysis of Conjunctival SCC in African and American Cohorts Reveal UV Light and HPV Signatures and High Tumor Mutation Burden. Investigative ophthalmology & visual science 65(4):24, 2024. e-Pub 2024. PMID: 38597722.
25. Contrera, KJ, Hassan, AM, Shuck, JW, Bobian, M, Ha, A, Chang, EI, Garvey, PB, Roubaud, MJ, Lee, Z, Hanasono, MM, Gross, N, Myers, JN, Yu, P, Largo, RD. Outcomes for 160 Consecutive Lateral Arm Free Flaps for Head and Neck Reconstruction. Otolaryngology - Head and Neck Surgery (United States) 170(3):747-757, 2024. e-Pub 2024. PMID: 38037485.
26. Maniakas A, Sullivan A, Hu MI, Busaidy NL, Cabanillas ME, Dadu R, Waguespack SG, Fisher SB, Graham PH, Gross ND, Grubbs EG, Perrier ND, Wang JR, Gunn B, Garden AS, Megahed R, Navuluri S, Li X, Williams MD, Zafereo M. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head Neck 46(2):328-335, 2024. e-Pub 2024. PMID: 38009416.
27. Burtness, B, Flamand, Y, Quon, H, Weinstein, GS, Mehra, R, Garcia, JJ, Kim, S, O’Malley, BW, Ozer, E, Koch, W, Gross, N, Bell, R, Patel, MR, Lango, MN, Morris, LG, Smith, RB, Karakla, DW, Richmon, JD, Holsinger, F, Ferris, R. Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC). Journal of Clinical Oncology 42(16), 2024. e-Pub 2024.
28. Zheng G, Zhang H, Lin F, Zafereo M, Gross ND, Sun P, Liu Y, Sun H, Wu G, Wei S, Wu J, Mao N, Li G, Wu G, Zheng H, Song X. Performance of CT-based deep learning in diagnostic assessment of suspicious lateral lymph nodes in papillary thyroid cancer: a prospective diagnostic study. Int J Surg 109(11):3337-3345, 2023. e-Pub 2023. PMID: 37578434.
29. Gross ND, Miller DM, Khushalani NI, Divi V, Ruiz ES, Lipson EJ, Meier F, Su YB, Swiecicki PL, Atlas J, Geiger JL, Hauschild A, Choe JH, M Hughes BG, Schadendorf D, Patel VA, Homsi J, Taube JM, Lim AM, Ferrarotto R, Yoo S, Mathias M, Han H, Seebach F, Lowy I, Fury MG, Rischin D. Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study. The Lancet Oncology 2045(23):00459, 2023. e-Pub 2023. PMID: 37875144.
30. Ferrarotto R, Nagarajan P, Maronge JM, Johnson JM, Rosenthal DI, Myers JN, Gross ND. Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial. JAMA Otolaryngol Head Neck Surg 149(9):847-849, 2023. e-Pub 2023. PMID: 37535378.
31. Niu Z, Sun P, Liu H, Wei P, Wu J, Huang Z, Gross ND, Shete S, Wei Q, Zafereo ME, Calin GA, Li G. Functional genetic variants in TGF-β1 and TGF-βR1 in microRNA binding sites predict outcomes in patients with HPV-positive oropharyngeal squamous cell carcinoma. Clin Cancer Res 29(16):3081-3091, 2023. e-Pub 2023. PMID: 37327315.
32. Sun P, Wei P, Liu H, Wu J, Gross ND, Sikora AG, Wei Q, Shete S, Zafereo ME, Liu J, Li G. GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy. EBioMedicine 94:104722, 2023. e-Pub 2023. PMID: 37487414.
33. Baruch, EN, Nagarajan, P, Gleber-Netto, FO, Rao, X, Xie, T, Akhter, S, Adewale, A, Shajedul, I, Mattson, BJ, Ferrarotto, R, Wong, MK, Davies, MA, Jindal, S, Basu, S, Harwood, C, Leigh, I, Ajami, NJ, Futreal, A, Castillo, M, Gunaratne, PH, Goepfert, RP, Khushalani, N, Wang, J, Watowich, SS, Calin, GA, Migden, MR, Vermeer, PD, D'Silva, NJ, Yaniv, D, Burks, JK, Gomez, JA, Dougherty, PM, Tsai, KY, Allison, JP, Sharma, P, Wargo, J, Myers, JN, Gross, N, Amit, M. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. Research square, 2023. e-Pub 2023. PMID: 37503252.
34. Amit M, Baruch E, Nagarajan P, Gleber-Netto F, Rao X, Xie T, Akhter S, Adewale A, Islam S, Mattson B, Ferrarotto R, Wong M, Davies M, Jindal S, Basu S, Harwood C, Leigh I, Ajami N, Futreal A, Castillo M, Gunarante P, Goepfert R, Khushalani N, Wang J, Watowich S, Calin G, Migden M, Vermeer P, D'Silva N, Yaniv D, Burks J, Gomez J, Dougherty P, Tsai K, Allison J, Sharma P, Wargo J, Myers J, Gross ND. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade. Res Sq, 2023. e-Pub 2023. PMID: 37503252.
35. Chen HY, Zhao W, Na'ara S, Gleber-Netto FO, Xie T, Ali S, Thompson ZM, Buell J, Stafford H, Nagarajan P, Davies M, Wong MK, Migden MR, Sharma P, Myers JN, Gross ND, Amit M. Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer. JCO Precis Oncol 7:e2200490, 2023. e-Pub 2023. PMID: 37285560.
36. Yang Z, Sun P, Dahlstrom KR, Gross ND, Li G. Joint effect of human papillomavirus exposure, smoking and alcohol on risk of oral squamous cell carcinoma. BMC Cancer 23(1):457, 2023. e-Pub 2023. PMID: 37202767.
37. Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L, Learned KO, Chasen NN, Vu T, Maniakas A, Eguia AA, Diersing J, Gross ND, Goepfert R, Lai SY, Hofmann M, Ferrarotto R, Lu C, Gunn GB, Spiotto MT, Subbiah V, Williams MD, Cabanillas ME, Zafereo ME. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. Thyroid 33(4):484-491, 2023. e-Pub 2023. PMID: 36762947.
38. Shenson JA, Zafereo ME, Lee M, Contrera KJ, Feng L, Boonsripitayanon M, Gross ND, Goepfert R, Maniakas A, Wang JR, Grubbs L, Vaporciyan A, Hofstetter W, Swisher S, Mehran R, Rice D, Sepesi B, Antonoff M, Cabanillas M, Busaidy N, Dadu R, Silver NL. Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer. Head & Neck 45(3):547-554, 2023. e-Pub 2022. PMID: 36524701.
39. Goldfarb JA, Ferrarotto R, Gross ND, Goepfert R, Debnam JM, Gunn B, Nagarajan P, Esmaeli B. Immune checkpoint inhibitors for treatment of periorbital squamous cell carcinoma. Br J Ophthalmol 107(3):320-323, 2023. e-Pub 2023. PMID: 34625433.
40. Hemmati M, Barbon C, Mohamed ASR, van Dijk LV, Moreno AC, Gross ND, Goepfert RP, Lai SY, Hutcheson KA, Schaefer AJ, Fuller CD, Head MD, Working Group NCS. Optimized Decision Support for Selection of Transoral Robotic Surgery or (Chemo)Radiation Therapy Based on Post-Treatment Swallowing Toxicity. Cancer Med 12(4):5088-5098, 2023. e-Pub 2023. PMID: 36229990.
41. Hemmati M, Barbon C, R Mohamed AS, van Dijk LV, Moreno AC, Gross ND, Goepfert RP, Lai SY, Hutcheson KA, Schaefer AJ, Fuller CD, Head MD, Working Group NCS. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Cancer Medicine 12(4):5088-5098. e-Pub 2023. PMID: 36229990.
42. Hardman JC, Holsinger FC, Brady GC, Beharry A, Bonifer AT, D'Andréa G, Dabas SK, de Almeida JR, Duvvuri U, Floros P, Ghanem TA, Gorphe P, Gross ND, Hamilton D, Kurukulasuriya C, Larsen MHH, Lin DJ, Magnuson JS, Meulemans J, Miles BA, Moore EJ, Pantvaidya G, Roof S, Rubek N, Simon C, Subash A, Topf MC, Van Abel KM, Vander Poorten V, Walgama ES, Greenlay E, Potts L, Balaji A, Starmer HM, Stephen S, Roe J, Harrington K, Paleri V. Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study. J Natl Cancer Inst 114(10):1400-1409, 2022. e-Pub 2022. PMID: 35944904.
43. Barbon CEA, Yao CMK, Peterson CB, Moreno AC, Goepfert RP, Johnson FM, Chronowski GM, Fuller CD, Gross ND, Hutcheson KA. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer. Otolaryngol Head Neck Surg 167(3):484-493, 2022. e-Pub 2022. PMID: 34784256.
44. Gross ND, Miller DM, Khushalani NI, Divi V, Ruiz ES, Lipson EJ, Meier F, Su YB, Swiecicki PL, Atlas J, Geiger JL, Hauschild A, Choe JH, Hughes BGM, Schadendorf D, Patel VA, Homsi J, Taube JM, Lim AM, Ferrarotto R, Kaufman HL, Seebach F, Lowy I, Yoo SY, Mathias M, Fenech K, Han H, Fury MG, Rischin D. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. N Eng J Med 387(17):1557-1568, 2022. e-Pub 2022. PMID: 36094839.
45. Taku N, Chronowski G, Brandon Gunn G, Morrison WH, Gross ND, Moreno AC, Ferrarotto R, Frank SJ, Fuller CD, Goepfert RP, Phan J, Lai SY, Reddy JP, Rosenthal DI, Garden AS. Unilateral Radiation Therapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papillomavirus, Positron-Emission Tomography, and Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 113(5):1054-1062, 2022. e-Pub 2022. PMID: 35504500.
46. Wang JR, Montierth M, Xu L, Goswami M, Zhao X, Cote G, Wang W, Iyer P, Dadu R, Busaidy NL, Lai SY, Gross ND, Ferrarotto R, Lu C, Gunn GB, Williams MD, Routbort M, Zafereo ME, Cabanillas ME. Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO Precis Oncol 6:e2100504, 2022. e-Pub 2022. PMID: 35977347.
47. Farah M, Milton DR, Gross ND, Nagarajan P, Gu J, Curry JL, Ivan D, Torres-Cabala CA, Myers JN, Prieto VG, Aung PP. Histopathologic features predictive of metastasis and survival in 230 patients with cutaneous squamous cell carcinoma of the head and neck and non-head and neck locations: a single-center retrospective study. J Eur Acad Dermatol Venereol 36(8):1246-1255, 2022. e-Pub 2022. PMID: 35426183.
48. Oliver JR, Persky MJ, Wang B, Duvvuri U, Gross ND, Vaezi AE, Morris LGT, Givi B. Transoral robotic surgery adoption and safety in treatment of oropharyngeal cancers. Cancer 128(4):685-696, 2022. e-Pub 2022. PMID: 34762303.
49. Urdang ZD, Rosales DH, Chen Q, Li RJ, Andersen PE, Gross ND, Clayburgh DR. Follow-Up Phone Interviews and Attendance Motivation From A Free Head and Neck Cancer Screening. Ear Nose Throat J 101(2):145561320940866, 2022. e-Pub 2022. PMID: 32703031.
50. Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, Garcia JJ, Chung CH, Gillison ML, Duvvuri U, O'Malley BW, Ozer E, Thomas GR, Koch WM, Gross ND, Bell RB, Saba NF, Lango M, Méndez E, Burtness B. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol 40(2):JCO2101752, 2022. e-Pub 2022. PMID: 34699271.
51. Glasbey, JC, Omar, O, Nepogodiev, D, Minaya-Bravo, AM, Bankhead-Kendall, BK, Fiore, M, Futaba, K, Gujjuri, RR, Isik, A, Kaafarani, HM, Kamarajah, S, Li, E, Löffler, MW, McLean, KA, Oumaima, O, Faustin, N, Sohei, S, Shaw, R, Simoes, JF, Stewart, GD, Tabiri, S, Trout, IM, Bhangu, A, Siaw-Acheampong, K, Benson, R, Bywater, E, Chaudhry, D, Dawson, BE, Evans, JP, Heritage, E, Jones, CS, Khatri, C, Khaw, R, Keatley, JM, Knight, A, Lawday, S, Mann, HS, Marson, EJ, McKay, SC, Mills, EC, Pellino, G, Picciochi, M, Taylor, EH, Tiwari, A, Venn, ML, Wilkin, RJ, Aneel, B, Passot, G, Gross, N, Roland, CL. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. British Journal of Surgery 108(1):88-96, 2021. e-Pub 2021. PMID: 33640908.
52. McLean KA, Kamarajah SK, Chaudhry D, Gujjuri RR, Raubenheimer K, et al...., Gross ND. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. Br J Surg 108(12):1448-1464, 2021. e-Pub 2021. PMID: 34871379.
53. Amit M, Liu C, Mansour J, Gleber-Netto FO, Tam S, Baruch EN, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Tsai K, Flores ER, Migden MR, Silverman DA, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma. Cancer 127(23):4413-4420, 2021. e-Pub 2021. PMID: 34358340.
54. Glasbey, J, Ademuyiwa, A, Adisa, AO, Alameer, E, Arnaud, AP, Ayasra, F, Azevedo, J, Minaya-Bravo, AM, Costas-Chavarri, A, Elhadi, M, Fiore, M, Fotopoulou, C, Gallo, G, Ghosh, D, Griffiths, EA, Harrison, E, Hutchinson, P, Lawani, I, Lawday, S, Lederhuber, H, Leventoglu, S, Li, E, Gomes, GA, Mann, H, Marson, EJ, Martin, J, Mazingi, D, McLean, KA, Modolo, M, Moore, R, Morton, DG, Ntirenganya, F, Pata, F, Picciochi, M, Pockney, PG, Ramos-De la Medina, A, Roberts, KJ, Roslani, AC, Kottayasamy Seenivasagam, R, Shaw, R, Simoes, JF, Smart, N, Stewart, GD, Sullivan, R, Sundar, S, Tabiri, S, Kowalski, LP, Vartanian, JG, Gross, N, Roland, CL. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries. The lancet oncology 22(11):1507-1517, 2021. e-Pub 2021. PMID: 34624250.
55. A Barbon CE, PhD, L Yao CMK, MD, Alvarez CP, MS, Goepfert RP, MD, Fuller CD, PhD, Lai SY, PhD, Gross ND, MD, A Hutcheson AK, PhD. Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis. Head and Neck 43(10):2883-2895, 2021. e-Pub 2021. PMID: 34080249.
56. Ferrarotto, R, Amit, M, Nagarajan, P, Rubin, ML, Yuan, Y, Bell, D, El-Naggar, AK, Johnson, JM, Morrison, WH, Rosenthal, D, Glisson, BS, Johnson, FM, Lu, C, Mott, FE, Esmaeli, B, Diaz Jr, EM, Gidley, PW, Goepfert, RP, Lewis, CM, Weber, RS, Wargo, J, Basu, S, Duan, F, Yadav, SS, Sharma, P, Allison, JP, Myers, JN, Gross, N. Pilot phase II trial of neoadjuvant immunotherapy in locoregionally advanced, resectable cutaneous squamous cell carcinoma of the head and neck. Clinical Cancer Research 27(16):4557-4565, 2021. e-Pub 2021. PMID: 34187851.
57. Ferrarotto R, Amit M, Nagarajan P, Rubin ML, Yuan Y, Bell D, El-Naggar AK, Johnson JM, Morrison WH, Rosenthal DI, Glisson BS, Johnson FM, Lu C, Mott FM, Esmaeli B, Diaz EM, Gidley PW, Goepfert RP, Lewis CM, Weber RS, Wargo JA, Basu S, Duan F, Yadav SS, Sharma P, Allison JP, Myers JN, Gross ND. Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res, 2021. e-Pub 2021.
58. Shaw, R, Winter, SC, Glasbey, JC, Ho, MS, Jackson, R, Cicconi, S, Ganly, I, Batstone, M, Rey Biel, J, Nankivell, PC, Simon, C, Omar, O, Simoes, JF, Nepogodiev, D, Bhangu, A, Schache, AG, Jackson, R, Cicconi, S, Siaw-Acheampong, K, Benson, RA, Bywater, E, Chaudhry, D, Dawson, BE, Evans, JP, Gujjuri, RR, Heritage, E, Jones, CS, Kamarajah, S, Khatri, C, Khaw, R, Keatley, JM, Knight, A, Lawday, S, Li, E, Mann, HS, Marson, EJ, McLean, KA, McKay, SC, Mills, EC, Nepogodiev, D, Pellino, G, Picciochi, M, Taylor, EH, Tiwari, A, Simoes, JF, Trout, IM, Venn, ML, Wilkin, RJ, Bhangu, A, Gross, N. Head and neck cancer surgery during the COVID-19 pandemic. Cancer 127(14):2476-2488, 2021. e-Pub 2021. PMID: 33345297.
59. Sherry AD, Pasalic D, Gunn G, Fuller C, Phan J, Rosenthal DI, Morrison WH, Sturgis EM, Gross ND, Gillison ML, Ferrarotto R, El-Naggar AK, Garden AS, Frank SJ. Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life. International Journal of Particle Therapy 8(1):234-247, 2021. e-Pub 2021. PMID: 34285950.
60. Kiong KL, Diaz EM, Gross ND, Diaz EM, Hanna EY. The impact of COVID-19 on head and neck cancer diagnosis and disease extent. Head Neck 43(6):1890-1897, 2021. e-Pub 2021. PMID: 33650276.
61. Bahig H, MD, PhD, Gunn BG, MD, Garden AS, MD, Ye R, MSc, Hutcheson K, PhD, Rosenthal DI, MD, Phan J, MD, PhD, Fuller CD, MD, PhD, Morrison WH, MD, PhD, Reddy JP, MD, PhD, Ng SP, MBBS, FRANZCR, Gross ND, MD, Sturgis EM, MD, MPH, Ferrarotto R, MD, Gillison M, MD, PhD, J Frank AS, MD. Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer. International Journal of Particle Therapy 8(1):213-222, 2021. e-Pub 2021. PMID: 34285948.
62. Sweeney KJ, Tetzlaff MT, Vega F, Gillenwater A, Zuo Z, Gross ND, Nagarajan P, Wargo J, Nelson K, Prieto VG, Torres-Cabala CA, Curry JL. Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response. J Cutan Pathol 48(5):674-679, 2021. e-Pub 2021. PMID: 33399228.
63. Tam S, Gajera M, Luo X, Glisson BS, Ferrarotto R, Johnson FM, Mott FE, Gillison ML, Lu C, Le X, Blumenschein GR, Wong MK, Rosenthal DI, Nagarajan P, El-Naggar AK, Midgen MR, Weber RS, Myers JN, Gross ND. Cytotoxic and Targeted Systemic Therapy in Patients with Advanced Cutaneous Squamous Cell Carcinoma in the Head and Neck. Head Neck 43(5):1592-1603, 2021. e-Pub 2021. PMID: 33522021.
64. Eskander A, Sahovaler A, Shin J, Deutsch K, Crowson M, Goyal N, Witsell DL, Schulz K, Gross ND, Weber R, Khariwala SS, Cohen S, CyrLee DW, Mehta V. A preliminary assessment of guideline adherence and clinical variation in oral cancer treatment: a MarketScan database study. BMC Oral Health 21(1):270, 2021. e-Pub 2021. PMID: 34001080.
65. Amit M, Liu C, Gleber-Netto FO, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Baruch EN, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck. Cancer 127(8):1238-1245, 2021. e-Pub 2021. PMID: 33320343.
66. Christopherson KM, Moreno AC, Elgohari B, Gross ND, Ferrarotto R, Mohamed ASR, Brandon Gunn G, Goepfert RP, Mott FE, Shah SJ, David Fuller C, Reddy JP, Frank SJ, Morrison WH, Phan J, Rosenthal DI, Garden AS. Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation. Oral Oncol 113:105125, 2021. e-Pub 2021. PMID: 33360375.
67. Amit M, Liu C, Netto Gleber FO, Kini S, Tam S, Benov A, Aashiq M, El-Naggar AK, Moreno AC, Rosenthal DI, Glisson BS, Ferrarotto R, Wong MK, Migden MR, Li G, Khanna A, Goepfert RP, Nagarajan P, Weber RS, Myers JN, Gross ND. Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck. Eur J Cancer 144:169-177, 2021. e-Pub 2021. PMID: 33352413.
68. Appelbaum EN, Gross ND, Diab A, Bishop AJ, Nader ME, Gidley PW. Melanoma of the External Auditory Canal: A Review of Seven Cases at a Tertiary Care Referral Center. Laryngoscope 131(1):165-172, 2021. e-Pub 2021. PMID: 32065414.
69. Glasbey, JC, Nepogodiev, D, Simoes, JF, Omar, O, Li, E, Venn, ML, Chaar, MK, Capizzi, V, Chaudhry, D, Desai, A, Edwards, JG, Evans, JP, Fiore, M, Videria, JF, Ford, SJ, Ganly, I, Griffiths, EA, Gujjuri, RR, Kolias, AG, Kaafarani, HM, Minaya-Bravo, AM, McKay, SC, Mohan, HM, Roberts, KJ, Miguel-Méndez, CS, Pockney, PG, Shaw, R, Smart, N, Stewart, GD, Sundar, S, Vidya, R, Bhangu, A, Allemand, C, Boccalatte, L, Figari, M, Lamm, M, Larrañaga, J, Marchitelli, C, Noll, F, Odetto, D, Perrotta, M, Saadi, J, Zamora, L, Alurralde, C, Caram, EL, Eskinazi, D, Mendoza, JP, Passot, G, Gross, N, Roland, CL. Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic. Journal of Clinical Oncology 39(1):66-78, 2021. e-Pub 2021. PMID: 33021869.
70. Collaborative C. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. Euro J Surg Oncol, 2021. e-Pub 2021.
71. Khanna A, Sturgis EM, Dahlstrom KR, Xu L, Wei Q, Li G, Gross ND. Association of pretreatment body mass index with risk of head and neck cancer: a large single-center study. Am J Cancer Res 11(5):2343-2350, 2021. e-Pub 2021. PMID: 34094690.
72. Boukovalas S, Goepfert RP, Smith JM, Mecham E, Liu J, Zafereo ME, Chang EI, Hessel AC, Hanasono MM, Gross ND, Yu P, Lewin JS, Lewis CM, Diaz EM, Weber RS, Myers JN, Offodile AC. Association between postoperative complications and long-term oncologic outcomes following total laryngectomy: 10-year experience at MD Anderson Cancer Center. Cancer 126(22):4905-4916, 2020. e-Pub 2020. PMID: 32931057.
73. Ferris RL, Flamand Y, Holsinger FC, Weinstein GS, Quon H, Mehra R, Garcia JJ, Hinni ML, Gross ND, Sturgis EM, Duvvuri U, Méndez E, Ridge JA, Magnuson JS, Higgins KA, Patel MR, Smith RB, Karakla DW, Kupferman ME, Malone JP, Judson BL, Richmon J, Boyle JO, Bayon R, O'Malley BW, Ozer E, Thomas GR, Koch WM, Bell RB, Saba NF, Li S, Sigurdson ER, Burtness B. A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311. Oral Oncol 110:104797, 2020. e-Pub 2020. PMID: 32679405.
74. Bagley AF, Garden AS, Reddy JP, Moreno AC, Frank SJ, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Shah SJ, Ferrarotto R, Sturgis EM, Gross ND, Phan J. Highly conformal reirradiation in patients with prior oropharyngeal radiation: Clinical efficacy and toxicity outcomes. Head Neck 42(11):3326-3335, 2020. e-Pub 2020. PMID: 32776401.
75. Shuck J, Chang EI, Mericli AF, Gross ND, Hanasono MM, Garvey PB, Yu P, Largo RD. Free Lateral Forearm Flap in Head and Neck Reconstruction: An Attractive Alternative to the Radial Forearm Flap. Plast Reconstr Surg 146(4):446e-450e, 2020. e-Pub 2020. PMID: 32590516.
76. Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, Sperling J, Gross ND, Sturgis EM, Goepfert RP, Lai SY, Cabanillas ME, Zafereo M. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol 6(9):1397-1404, 2020. e-Pub 2020. PMID: 32761153.
77. Yang Z, Qi X, Gross ND, Kou X, Bai Y, Feng Y, Wang B, Zafereo ME, Li G, Sun C, Li H, Chen X, Huang Z. The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A. J Cell Mol Med. e-Pub 2020. PMID: 32989896.
78. Maghami E, Ismaila N, Alvarez A, Chernock R, Duvvuri U, Geiger J, Gross ND, Haughey B, Paul D, Rodriguez C, Sher D, Stambuk HE, Waldron J, Witek M, Caudell J. Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline. J Clin Oncol 38(22):JCO2000275, 2020. e-Pub 2020. PMID: 32324430.
79. Ferrarotto R, Bell D, Rubin ML, Hutcheson KA, Johnson JM, Goepfert RP, Phan J, Elamin YY, Torman DK, Warneke CL, Hessel AC, Garden AS, Myers JN, Johnson FM, Lee JJ, Sikora AG, Gillison ML, Glisson BS, Gross ND. Impact of neoadjuvant durvalumab with or without tremelimumab on CD8+ tumor lymphocyte density, safety, and efficacy in patients with oropharynx cancer: CIAO trial. Clin Cancer Res 26(13):3211-3219, 2020. e-Pub 2020. PMID: 32269052.
80. Renata Ferrarotto, Bell D, Rubin ML, Katherine A. Hutcheson, Jason M. Johnson, Goepfert RP, Phan J, Elamin YY, Torman DK, Carla L. Warneke, Hessel AC, Garden AS, Jeffrey N. Myers, Faye M. Johnson, Lee J, Sikora AG, Gillison ML, Glisson BS, Gross ND. Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results. American Association for Cancer Research 26(13), 2020. e-Pub 2020. PMID: 32269052.
81. Head MD, Guidelines Consortium NST, Maniakas A, Jozaghi Y, Zafereo ME, Sturgis EM, Su SY, Gillenwater AM, Gidley PW, Lewis CM, Diaz E, Goepfert RP, Kupferman ME, Gross ND, Hessel AC, Pytynia KB, Nader ME, Wang JR, Lango MN, Kiong KL, Guo T, Zhao X, CMKL Y, Appelbaum E, Alpard J, Garcia JA, Terry S, Flynn JE, Bauer S, Fournier D, Burgess CG, Wideman C, Johnston M, You C, De Luna R, Joseph L, Diersing J, Prescott K, Heiberger K, Mugartegui L, Rodriguez J, Zendehdel S, Sellers J, Friddell RA, Thomas A, Khanjae SJ, Schwarzlose KB, Chambers MS, Hofstede TM, Cardoso RC, Wesson RA, Won A, Otun AO, Gombos DS, Al-Zubidi N, Hutcheson KA, Gunn GB, Rosenthal DI, Gillison ML, Ferrarotto R, Weber RS, Hanna EY, Myers JN, Lai SY. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck 42(6):1194-1201, 2020. e-Pub 2020. PMID: 32342541.
82. Kiong KL, Guo T, CMKL Y, Gross ND, Hanasono MM, Ferrarotto R, Rosenthal DI, Myers JN, Hanna EY, Lai SY. Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era. Head Neck 42(6):1179-1186, 2020. e-Pub 2020. PMID: 32459061.
83. Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
84. Barbon CE, Yao CM, Warneke CL, Elgohari B, Goepfert RP, Hessel AC, Kupferman ME, Lai S, Fuller CD, Gunn GB, Garden AS, Chronowski, Johnson FM, Lewin JS, Gross ND, Hutcheson KA. Dysphagia After Primary Tors vs Non-surgical Therapies for Low-to-Intermediate Risk Tonsil Cancer: A Prospective Registry Analysis. Int J Radiat Oncol Biol Phys, 2020. e-Pub 2020.
85. Lee YA, Al-Temimi M, Ying J, Muscat J, Olshan AF, Zevallos JP, Winn DM, Li G, Sturgis EM, Morgenstern H, Zhang ZF, Smith E, Kelsey K, McClean M, Vaughan TL, Lazarus P, Chen C, Schwartz SM, Gillison M, Schantz S, Yu GP, D'Souza G, Gross ND, Monroe M, Kim J, Boffetta P, Hashibe M. Head and Neck Cancer Risk Prediction Models for the US Population from the INHANCE Consortium. Am J Epidemiol 189(4):330-342, 2020. e-Pub 2020. PMID: 31781743.
86. Liu C, Gross ND, Li Y, Li G, Wang Z, Zhong S, Li Y, Hu G. PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells. J Cell Mol Med 24(4):2444-2450, 2020. e-Pub 2020. PMID: 31957270.
87. Tam S, CMKL Y, Amit M, Gajera M, Luo X, Treistman R, Khanna A, Aashiq M, Nagarajan P, Bell D, El-Naggar A, Migden M, Wong M, Glisson B, Ferrarotto R, Esmaeli B, Rosenthal D, Li G, Weber RS, Myers JN, Gross ND. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg 146(2):128-135, 2020. e-Pub 2020. PMID: 31804658.
88. Liu C, Liao K, Gross ND, Wang Z, Li G, Zuo W, Zhong S, Zhang Z, Zhang H, Yang J, Hu G. Homologous recombination enhances radioresistance in hypopharyngeal cancer cell line by targeting DNA damage response. Oral Oncol 100:104469, 2020. e-Pub 2020. PMID: 31756687.
89. Zhu Y, Xia X, Gross ND, Dahlstrom KR, Gao L, Liang Z, Gao Z, Wei P, Liu C, Li G, Li Y, Chen X. Prognostic implications of human papillomavirus status and p16 expression in laryngeal squamous cell carcinoma. Head Neck 41(12):4151-4163, 2019. e-Pub 2019. PMID: 31566825.
90. Xu X, Lu Z, Gross ND, Li G, Zhang F, Lei D, Pan X. A 3-miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after postoperative radiotherapy. J Cell Mol Med 23(12):8280-8291, 2019. e-Pub 2019. PMID: 31578816.
91. Tam S, MD, MPH, L Yao CMK, MD, Amit M, MD, PhD, Gajera M, BDS, Luo X, MD, PhD, Treistman R, BS, Khanna A, MPH, Aashiq M, MD, Nagarajan P, MD, PhD, Bell D, MD, El-Naggar A, MD, Migden M, MD, MichaelWong, MD, Glisson B, MD, Ferrarotto R, MD, Esmaeli B, MD, Rosenthal D, MD, Li G, PhD, SWeber R, MD, NMyers J, MD, PhD, Gross ND, MD. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Network 146(2):128-135, 2019. e-Pub 2019. PMID: 31804658.
92. Zhang Z, Zhou Z, Zhang M, Gross ND, Gong L, Zhang S, Lei D, Zeng Q, Luo X, Li G, Li X. High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment. Biomed Pharmacother 118:109306, 2019. e-Pub 2019. PMID: 31545250.
93. Zhang Y, Gross ND, Li Z, Yin G, Zhong Q, Liu C, Huang Z. Upregulation of BTF3 affects the proliferation, apoptosis, and cell cycle regulation in hypopharyngeal squamous cell carcinoma. Biomed Pharmacother 118:109211, 2019. e-Pub 2019. PMID: 31404775.
94. Hutcheson KA, Warneke CL, CMKL Y, Zaveri J, Elgohari BE, Goepfert R, Hessel AC, Kupferman ME, Lai SY, Fuller CD, Gunn GB, Garden AS, Johnson F, Ferrarotto R, Lewin JS, Gross ND, Head MD, Working Group NCS. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. e-Pub 2019. PMID: 31556933.
95. Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma. Thyroid 29(8):1036-1043, 2019. e-Pub 2019. PMID: 31319771.
96. Di Credico G, Edefonti V, Polesel J, Pauli F, Torelli N, Serraino D, Negri E, Luce D, Stucker I, Matsuo K, Brennan P, Vilensky M, Fernandez L, Curado MP, Menezes A, Daudt AW, Koifman R, Wunsch-Filho V, Holcatova I, Ahrens W, Lagiou P, Simonato L, Richiardi L, Healy C, Kjaerheim K, Conway DI, Macfarlane TV, Thomson P, Agudo A, Znaor A, Boaventura Rios LF, Toporcov TN, Franceschi S, Herrero R, Muscat J, Olshan AF, Zevallos JP, La Vecchia C, Winn DM, Sturgis EM, Li G, Fabianova E, Lissowska J, Mates D, Rudnai P, Shangina O, Swiatkowska B, Moysich K, Zhang ZF, Morgenstern H, Levi F, Smith E, Lazarus P, Bosetti C, Garavello W, Kelsey K, McClean M, Ramroth H, Chen C, Schwartz SM, Vaughan TL, Zheng T, Menvielle G, Boccia S, Cadoni G, Hayes RB, Purdue M, Gillison M, Schantz S, Yu GP, Brenner H, D'Souza G, Gross ND, Chuang SC, Boffetta P, Hashibe M, Lee YA, Dal Maso L. Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach. Oral Oncol 94:47-57, 2019. e-Pub 2019. PMID: 31178212.
97. Adelstein DJ, Ismaila N, Ku JA, Burtness B, Swiecicki PL, Mell L, Beitler JJ, Gross ND, Jones CU, Kaufman M, Le QT, Semrad TJ, Siu LL, Ridge JA. Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion. J Clin Oncol 37(18):1578-1589, 2019. e-Pub 2019. PMID: 31021656.
98. Xu J, Gross ND, Zang Y, Cao S, Yang F, Yang Z, Yu W, Lei D, Pan X. Overexpression of S100A4 predicts migration, invasion, and poor prognosis of hypopharyngeal squamous cell carcinoma. Mol Diagn Ther 23(3):407-417, 2019. e-Pub 2019. PMID: 30868407.
99. Nagarajan P, El-Hadad C, Gruschkus SK, Ning J, Hudgens CW, Sagiv O, Gross ND, Tetzlaff MT, Esmaeli B. PD-L1/PD1 Expression, Composition of Tumor-Associated Immune Infiltrate, and HPV Status in Conjunctival Squamous Cell Carcinoma. Invest Ophthalmol Vis Sci 60(6):2388-2398, 2019. e-Pub 2019. PMID: 31141610.
100. Cabanillas M, Busaidy N, Dadu R, Ferrarotto R, Gross ND, m G, Lu C, Grosu H, Williams M, Zafereo ME. OR27-6 Combination Vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL1 Inhibitor) in BRAF-V600E Mutated Anaplastic Thyroid Cancer (ATC): Initial Safety and Feasibility. J Endocr Soc, 2019. e-Pub 2019.
101. Amit M, Hutcheson K, Zaveri J, Lewin J, Kupferman ME, Hessel AC, Goepfert RP, Brandon Gunn G, Garden AS, Ferraratto R, Dave Fuller C, Tam S, Gross ND. Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry. Oral Oncol 91:13-20, 2019. e-Pub 2019. PMID: 30926057.
102. Zhang Y, Huang Z, Gross ND, Fang J, Chen X, Chen X, Hou L, Li P, Li G, Zhong Q. Multimodality Treatment Options and Outcomes of Laryngeal Carcinosarcoma: A Clinical Analysis of a Rare Tumor from a Single Hospital. Biomed Res Int 2019:1754675, 2019. e-Pub 2019. PMID: 31317023.
103. Cabanillas M, Iyer P, Cote G, Hai T, Gule-Monroe M, H Bui JH, Williams M, Hess KR, Hofmann MC, Dadu R, Zafereo ME, Busaidy L, Ferrarotto R, Subbiah V, Gross ND, Gunn B, Skinner H, Garden A. Circulating BRAF V600E cell free DNA (cfDNA) as a biomarker in the management of Anaplastic Thyroid Carcinoma. JCO Precis Oncol. e-Pub 2018.
104. Heah H, Goepfert RP, Hutcheson KA, Garden AS, Gunn GB, Fuller CD, Lewin JS, Kupferman ME, Holsinger FC, Hessel AC, Gross ND. Decreased Gastrostomy Tube Incidence and Weight Loss after Transoral Robotic Surgery for Low- to Intermediate-risk Oropharyngeal Squamous Cell Carcinoma. Head Neck 40(11):2507-2513, 2018. e-Pub 2018. PMID: 30102824.
105. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross ND, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA. Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma. Nat Med 24(11):1649-1654, 2018. e-Pub 2018. PMID: 30297909.
106. Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions. Thyroid 28(10):1301-1310, 2018. e-Pub 2018. PMID: 30141373.
107. Xu X, Liu H, Gross ND, Wei D, Qian Y, Li W, Wei P, Li G, Zhang F, Yang Z, Lei D, Pan X. Overexpression of miRNA 4451 is Associated with a Poor Survival of Patients with Hypopharyngeal Cancer after Surgery with Postoperative Radiotherapy. Transl Oncol 11(5):1244-1250, 2018. e-Pub 2018. PMID: 30103154.
108. Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Ann Surg Oncol 25(11):3380-3388, 2018. e-Pub 2018. PMID: 30022274.
109. Geltzeiler M, Bertolet M, Albergotti W, Gleysteen J, Olson B, Persky M, Gross ND, Li R, Andersen P, Kim S, Ferris RL, Duvvuri U, Clayburgh D. Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort. Oral Oncol 84:82-87, 2018. e-Pub 2018. PMID: 30115481.
110. Tam S, Amit M, Boonsripitayanon M, Busaidy NL, Cabanillas ME, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis EM, Zafereo ME. The Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid 28(8):982-990, 2018. e-Pub 2018. PMID: 29936892.
111. Iyer PC, Dadu R, Gule-Monroe M, Busaidy NL, Ferrarotto R, Habra MA, Zafereo M, Williams MD, Gunn GB, Grosu H, Skinner HD, Sturgis EM, Gross ND, Cabanillas ME. Salvage Pembrolizumab added to Kinase Inhibitor Therapy for the Treatment of Anaplastic Thyroid Carcinoma. J Immunother Cancer 6(1):68, 2018. e-Pub 2018. PMID: 29996921.
112. Tao Y, Gross ND, Fan X, Yang J, Teng M, Li X, Li G, Zhang Y, Huang Z. Identification of Novel Enriched Recurrent Chimeric COL7A1-UCN2 in Human Laryngeal Cancer Samples using Deep Sequencing. BMC Cancer 18(1):248, 2018. e-Pub 2018. PMID: 29499655.
113. Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Lymph Node Density as a Predictor of Outcome in Papillary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 144(2):108-114, 2018. e-Pub 2018. PMID: 29192312.
114. Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo M, Gross ND, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Real World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid 28(1):79-87, 2018. e-Pub 2018. PMID: 29161986.
115. Pena I, Clayman GL, Grubbs EG, Bergeron JM, Waguespack SG, Cabanillas ME, Dadu R, Hu MI, Fellman BM, Li Y, Gross ND, Lai SY, Sturgis EM, Zafereo ME. Management of the Lateral Neck Compartment in Patients with Sporadic Medullary Thyroid Cancer. Head Neck 40(1):79-85, 2018. e-Pub 2018. PMID: 29044788.
116. Achim V, Bolognone RK, Palmer AD, Graville DJ, Light TJ, Li R, Gross ND, Andersen PE, Clayburgh D. Long-Term Functional and Quality of Life Outcomes after Transoral Robotic Surgery for the Treatment of Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 144(1):18-27, 2018. e-Pub 2018. PMID: 29075740.
117. Tao Y, Tao T, Gross ND, Peng X, Li Y, Huang Z, Liu L, Li G, Chen X, Yang J. Combined Effect of IL-12Rβ2 and IL-23R Expression on Prognosis of Patients with Laryngeal Cancer. Cell Physiol Biochem 50(3):1041-1054, 2018. e-Pub 2018. PMID: 30355949.
118. Cao Y, Green K, Quattlebaum S, Milam B, Lu L, Gao D, He H, Li N, Gao L, Hall F, Whinery M, Handley E, Ma Y, Xu T, Jin F, Xiao J, Wei M, Smith D, Bornstein S, Gross ND, Pyeon D, Song J, Lu SL. Methylated Genomic Loci Encoding microRNA as a Biomarker Panel in Tissue and Saliva for Head and Neck Squamous Cell Carcinoma. Clin Epigenetics 10:43, 2018. e-Pub 2018. PMID: 29636832.
119. Tam S, Amit M, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Gunn GB, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer. JAMA Otolaryngol Head Neck Surg 143(12):1244-51, 2017. e-Pub 2017. PMID: 29098272.
120. Tao Y, Gross ND, Liu Y, Zhang L, Li G, Huang Z, Yang J. A High Ratio of IL-12R2-positive Tumor-infiltrating Lymphocytes Indicates Favorable Prognosis in Laryngeal Cancer. Oral Oncology 74(11):148-56, 2017. e-Pub 2017. PMID: 29103744.
121. Troob S, Givi B, Hodgson M, Mowery A, Gross ND, Andersen PE, Clayburgh D. Transoral Robotic Retropharyngeal Node Dissection in Oropharyngeal Squamous Cell Carcinoma: Patterns of Metastasis and Functional Outcomes. Head Neck 39(10):1969-75, 2017. e-Pub 2017. PMID: 28758272.
122. Head MD, Working Group NCS, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymar JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):150, 2017. e-Pub 2017. PMID: 28888224.
123. Clayburgh D, Stott W, Bolognone R, Palmer A, Achim V, Troob S, Li R, Brickman D, Graville D, Andersen P, Gross ND. A Randomized Controlled Trial of Corticosteroids for Pain after Transoral Robotic Surgery. Laryngoscope 127(11):2558-64. e-Pub 2017. PMID: 28850681.
124. Gleysteen J, Troob S, Light T, Brickman D, Clayburgh D, Andersen P, Gross ND. The Impact of Prophylactic External Carotid Artery Ligation on Postoperative Bleeding after Transoral Robotic Surgery (TORS) for Oropharyngeal Squamous Cell Carcinoma. Oral Oncology 65(2):89-93, 2017. e-Pub 2017. PMID: 28109475.
125. Light T, Rassi EE, Maggiore RJ, Holland J, Reed J, Suriano K, Stooksbury M, Tobin N, Gross ND, Clayburgh D. Improving Outcomes in Veterans with Oropharyngeal Squamous Cell Carcinoma through Implementation of a Multidisciplinary Clinic. Head Neck 39(6):1106-12, 2017. e-Pub 2017. PMID: 28370667.
126. Goepfert RP, Hutcheson KA, Lewin JS, Desai NG, Zafereo ME, Hessel AC, Lewis CM, Weber RS, Gross ND. Complications, Hospital Length of Stay, and Readmission after Total Laryngectomy. Cancer 123(10):1760-1767, 2017. e-Pub 2017. PMID: 28026864.
127. Rao S, Zafereo M, Dadu R, Busaidy N, Hess K, Cote G, Williams M, William W, Sandulache V, Gross ND, Gunn B, Lu C, Ferrarotto R, Lai S, Cabanillas M. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid 27(5):672-81, 2017. e-Pub 2017. PMID: 28068873.
128. Zhang Y, Waterboer T, Haddad RI, Miles BA, Wentz A, Gross ND, Fakhry C, Quong H, Lorch J, Gourin CG, Clayburgh D, Misiukiewicz KJ, Richmon JD, Andersen PE, Posner MR, D’Souza G. Human Papillomavirus (HPV) 16 Antibodies At Diagnosis of HPV-related Oropharyngeal Cancer and Antibody Trajectories After Treatment. Oral Oncology 67(4):77-82, 2017. e-Pub 2017. PMID: 28351584.
129. Sheu T, Vock D, Mohamed A, Gross ND, Mulachy C, Zafereo M, Gunn GB, Garden A, Parage S, Phan J, Lewin J, Frank S, Beadle B, Morrison W, Lai S, Hutcheson K, Marai GE, Canahuat G, Kies M, El-Naggar A, Rosenthal D, Weber R, Fuller C. Conditional Survival Analysis of Patients With Locally Advanced Laryngeal Cancer: Construction of a Dynamic Risk Model and Clinical Nomogram. Scientific Reports. e-Pub 2017. PMID: 28276466.
130. Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai SY, Gross ND, Schwartz DL, Hutcheson KA. Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 97(4):700-708, 2017. e-Pub 2017. PMID: 27485284.
131. Bauman JE, Duvvuri U, Gooding WE, Rath TJ, Gross ND, Song J, Jimeno A, Yarbrough WG, Johnson FM, Wang L, Chiosea S, Sen M, Kass J, Johnson JT, Ferris RL, Kim S, Hirsch FR, Ellison K, Flaherty JT, Mills GB, Grandis JR. Predictive Biomarkers of EGFR-Src Blockade in Operable Head and Neck Cancer: A Randomized, Double-blind Window Study. JCI Insight 2(6):e90449, 2017. e-Pub 2017. PMID: 28352657.
132. Gelzeiler M, Clayburgh D, Gleysteen J, Gross ND, Hamilton B, Anderson P, Brickman D. Predictors of Extracapsular Extension in HPV-Associated Oropharyngeal Cancer. Oral Oncology 65(2):89-93, 2017. e-Pub 2017. PMID: 28109475.
133. Du L, Chen X, Cao Y, Lu L, Zhang F, Bornstein S, Li Y, Owens P, Malkoski S, Said S, Jin F, Kulesz-Martin M, Gross ND, Wang XJ, Lu SL. Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGFβ signaling. Oncogene 35(35):4641-52, 2016. e-Pub 2016. PMID: 26876212.
134. Gross ND, Holsinger FC, Magnuson JS, Duvvuri U, Genden EM, Ghanem TA, Yaremchuk KL, Goldenberg D, Miller MC, Moore EJ, Morris LG, Netterville J, Weinstein GS, Richmon J. Robotics In Otolaryngology and Head and Neck Surgery: Recommendations for Training and Credentialing; A Report of the 2015 AHNS Education Committee, AAO-HNS Robotic Task Force and AAO-HNS Sleep Disorders Committee. Head Neck 38(Suppl 1):E151-8, 2016. e-Pub 2016. PMID: 26950771.
135. Givi B, Troob SH, Stott W, Cordeiro T, Andersen PE, Gross ND. Transoral Robotic Retropharyngeal Node Dissection. Head Neck 38(Suppl 1):E981-6, 2016. e-Pub 2016. PMID: 26040490.
136. Dale T, Hutcheson K, Mohamed AS, Lewin JS, Gunn GB, Rao AU, Kalpathy-Cramer J, Frank SJ, Garden AS, Messer JA, Warren B, Lai SY, Beadle BM, Morrison WH, Phan J, Skinner H, Gross ND, Ferrarotto R, Weber RS, Rosenthal D, Fuller CD. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. Radiother Oncol 118(2):304-14, 2016. e-Pub 2016. PMID: 26897515.
137. Rettig EM, Wentz A, Posner MR, Gross ND, Haddad RI, Gillison ML, Fakhry C, Quon H, Sikora AG, Stott WJ, Lorch JH, Gourin CG, Guo Y, Xiao W, Miles BA, Richmon JD, Andersen PE, Misiukiewicz KJ, Chung CH, Gerber JE, Rajan SD, D'Souza G. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma. JAMA Oncol 1(7):907-15, 2015. e-Pub 2015. PMID: 26226294.
138. Anderson KS, Gerber JE, D'Souza G, Pai SI, Cheng JN, Alam R, Kesiraju S, Chowell D, Gross ND, Haddad R, Gillison ML, Posner M. Biologic Predictors of Serologic Responses to HPV in Oropharyngeal Cancer: The HOTSPOT Study. Oral Oncol 51(8):751-8, 2015. e-Pub 2015. PMID: 26094591.
139. Anderson KS, Dahlstrom KR, Cheng JN, Alam R, Li G, Wei Q, Gross ND, Chowell D, Posner M, Sturgis EM. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status. Oral Oncol 51(7):662-7, 2015. e-Pub 2015. PMID: 25957822.
140. Hooper JE, Hebert JF, Schilling A, Gross ND, Schindler JS, Lagowski JP, Kulesz-Martin M, Corless CL, Morgan TK. Hybrid Capture 2 is as effective as PCR testing for high-risk human papillomavirus in head and neck cancers. Appl Immunohistochem Mol Morphol 23(4):266-72, 2015. e-Pub 2015. PMID: 25839700.
141. Geltzeiler M, Monroe M, Givi B, Vetto J, Andersen P, Gross ND. Regional Control of Head and Neck Melanoma with Selective Neck Dissection. JAMA Otolaryngol Head Neck Surg 140(11):1014-8, 2014. e-Pub 2014. PMID: 25275362.
142. D'Souza G, Gross ND, Pai SI, Haddad R, Anderson KS, Rajan S, Gerber J, Gillison ML, Posner MR. Oral Human Papillomavirus (HPV) Infection in HPV-Positive Patients With Oropharyngeal Cancer and Their Partners. J Clin Oncol 32(23):2408-15, 2014. e-Pub 2014. PMID: 24778397.
143. Gross ND, Bauman JE, Gooding WE, Denq W, Thomas SM, Wang L, Chiosea S, Hood BL, Flint MS, Sun M, Conrads TP, Ferris RL, Johnson JT, Kim S, Argiris A, Wirth L, Nikiforova MN, Siegfried JM, Grandis JR. Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer. Clin Cancer Res 20(12):3289-98, 2014. e-Pub 2014. PMID: 24727329.
144. Chia SH, Gross ND, Richmon JD. Surgeon experience and complications with Transoral Robotic Surgery (TORS). Otolaryngol Head Neck Surg 149(6):885-92, 2013. e-Pub 2013. PMID: 24013139.
145. Clayburgh D, Stott W, CordieroT, Park R, Detwiller K, Buniel M, Flint P, Schindler J, Andersen P, Wax M, Gross ND. Prospective Study of Venous Thromboembolism in Patients with Head and Neck Cancer after Surgery. JAMA Otolaryngol Head Neck Surg 139(6):1143-50, 2013. e-Pub 2013. PMID: 24076972.
146. Patel SA, Magnuson JS, Holsinger FC, Karni RJ, Richmon JD, Gross ND, Bhrany AD, Ferrell JK, Ford SE, Kennedy AA, Méndez E. Robotic surgery for primary head and neck squamous cell carcinoma of unknown site. JAMA Otolaryngol Head Neck Surg 139(11):1203-11, 2013. e-Pub 2013. PMID: 24136446.
147. Monroe MM, McLean M, Sautter N, Wax MK, Andersen PE, Smith TL, Gross ND. Invasive fungal rhinosinusitis: a 15-year experience with 29 patients. Laryngoscope 123(7):1583-7, 2013. e-Pub 2013. PMID: 23417294.
148. Wang SJ, Patel SG, Shah JP, Goldstein DP, Irish JC, Carvalho AL, Kowalski LP, Lockhart JL, Holland JM, Gross ND. An oral cavity carcinoma nomogram to predict benefit of adjuvant radiotherapy. JAMA Otolaryngol Head Neck Surg 139(6):554-9, 2013. e-Pub 2013. PMID: 23680917.
149. Clayburgh D, Stott W, Kochanowski T, Park R, Detwiller K, Buniel M, Flint P, Schindler J, Andersen P, Wax M, Gross ND. Prospective study of venous thromboembolism in patients with head and neck cancer after surgery: interim analysis. JAMA Otolaryngol Head Neck Surg 139(2):161-7, 2013. e-Pub 2013. PMID: 23429947.
150. Thai L, McCarn K, Stott W, Watts T, Wax MK, Andersen PE, GROSS ND. Venous thromboembolism in patients with head and neck cancer after surgery. Head Neck 35(1):4-9, 2013. e-Pub 2013. PMID: 22302625.
151. Clayburgh DR, Gross ND, Proby C, Koide J, Wong MH. Effects of epidermal growth factor receptor and insulin-like growth factor 1 receptor inhibition on proliferation and intracellular signaling in cutaneous SCCHN: potential for dual inhibition as a therapeutic modality. Head Neck 35(1):86-93, 2013. e-Pub 2013. PMID: 22495823.
152. Moskowitz HS, Gooding WE, Thomas SM, Frelino ML, Gross ND, Argiris A, Grandis JR, Ferris BL. Serum Biomarkers Modulation Following Molecular Targeting of Epidermal Growth Factors and Cycloxygenase Pathways: a Pilot Randomized Trial in Head and Neck Cancer. Oral Oncol 48(11):1136-45, 2012. e-Pub 2012.
153. Lindau R, Wolters K, Gross ND, Wax M. Riedel's Disease: Report of Extensive Disease Requiring a Total Laryngectomy. Otolaryngol Head Neck Surgery 147(4):799-800, 2012. e-Pub 2012.
154. Schneider DS, Gross ND, Sheppard BC, Wax MK. Reconstruction of the jejunoesophageal anastomosis with a circular mechanical stapler in total laryngopharyngectomy defects. Head Neck 34(5):721-6, 2012. e-Pub 2012. PMID: 21739517.
155. Minor J, Wang X, Zhang F, Song J, Jimeno A, Wang XJ, Lu X, Gross ND, Kulesz-Martin M, Lu SL. Methylation of MicroRNA-9 is a Specific and Sensitive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinomas. Oral Oncol 48(1):73-8, 2012. e-Pub 2012.
156. Wester JL, Clayburgh DR, Stott WJ, Schindler JS, Andersen PE, Gross ND. Airway reconstruction in Wegener's granulomatosis-associated laryngotracheal stenosis. Laryngoscope 121(12):2566-71, 2011. e-Pub 2011. PMID: 22109754.
157. Hamilton BE, Nesbit GM, Gross ND, Andersen P, Sauer D, Harnsberger HR. Characteristic Imaging Findings in Lymphoceles of the Head and Neck. Am J Roentgenol 197(6):1431-5, 2011. e-Pub 2011.
158. Miller MW, Vetto JT, Monroe MM, Weerasinghe R, Andersen PE, Gross ND. False-negative sentinel lymph node biopsy in head and neck melanoma. Otolaryngol Head Neck Surg 145(4):606-11, 2011. e-Pub 2011. PMID: 21659495.
159. Monroe MM, McLean M, Gross ND. Infected tracheal diverticulum presenting as a cervical abscess. Otolaryngol Head Neck Surg 145(3):513-4, 2011. e-Pub 2011. PMID: 21493282.
160. Wang SJ, Wissel AR, Ord CB, Kalpathy-Cramer J, Fuller CD, Holland JM, Gross ND. Individualized estimation of conditional survival for patients with head and neck cancer. Otolaryngol Head Neck Surg 145(1):71-3, 2011. e-Pub 2011. PMID: 21493289.
161. Givi B, Andersen PE, Diggs BS, Wax MK, Gross ND. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Head Neck 33(7):999-1004, 2011. e-Pub 2011. PMID: 21284049.
162. Paulson LM, Thompson J, Hooper JE, Hamilton BE, Gross ND. Radiology quiz case 2. Cervical foregut duplication cyst. Arch Otolaryngol Head Neck Surg 137(7):718, 721, 2011. e-Pub 2011. PMID: 21768421.
163. Nicky N, Thompson M, Rossmiller S, Gross ND, White C, Gatter K. Diagnostic Pitfalls in Syringocystadenocarcinoma Papilliferum Case Report and Review. Arch Path Lab Med 134:1205-09, 2010. e-Pub 2010.
164. Salter KD, Andersen PE, Cohen JI, Schuff KG, Lester L, Shindo ML, Sauer D, Gross ND. Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality. Arch Otolaryngol Head Neck Surg 136(7):692-6, 2010. e-Pub 2010. PMID: 20644065.
165. Gross ND, Ganly I, Patel SG, Bilsky MH, Shah JP, Kraus DH. Results of anterior skull base surgery in pediatric and young adult patients. Skull Base 20(2):75-81, 2010. e-Pub 2010. PMID: 20808531.
166. Gross ND, Ganly I, Patel SG, Bilsky MH, Shah JP, Kraus DK. Results of Anterior Skull Base Surgery in Pediatric and Young Adults Patients. Skull Base 20(2):75-81, 2010. e-Pub 2010.
167. Kekatpure VD, Boyle JO, Zhou XK, Duffield-Lillico AJ, Gross ND, Lee NY, Subbaramaiah K, Morrow JD, Milne G, Lippman SM, Dannenberg AJ. Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res 2(11):957-65, 2009. e-Pub 2009. PMID: 19843689.
168. Bornstein S, White R, Malkoski S, Oka M, Han G, Cleaver T, Reh D, Andersen P, Gross ND, Olson S, Deng C, Lu SL, Wang XJ. Smad4 Loss Causes Spontaneous Head and Neck Cancer with Increased Genomic Instability and Inflammation. J Clin Invest 119(11):3408-19, 2009. e-Pub 2009.
169. Rossmiller SR, Ghanem TA, Gross ND, Wax MK. Modified ileocolic free flap: viable choice for reconstruction of total laryngopharyngectomy with total glossectomy. Head Neck 31(9):1215-9, 2009. e-Pub 2009. PMID: 19360747.
170. Monroe MM, Sauer DA, Samuels MH, Gross ND. Pathology quiz case 1. Coexistent conventional mucoepidermoid carcinoma of the thyroid (MECT) and papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 135(7):720, 722, 2009. e-Pub 2009. PMID: 19620598.
171. Gross ND, Patel SG, Carvalho AL, Chu PY, Kowalski LP, Boyle JO, Shah JP, Kattan MW. Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck 30(10):1352-60, 2008. e-Pub 2008. PMID: 18720518.
172. McCarn KE, Ghanem T, Tartaglia J, Gross ND, Andersen P, Wax MK. Second Free Tissue Transfer in Head and Neck Reconstruction. Otolaryngol Head Neck Surgery 139(4):525-9, 2008. e-Pub 2008.
173. Lo JO, Weber SM, Andersen PE, Gross ND, Gosselin M, Wax MK. Atelectasis after free rectus transfer and abdominal wall reconstruction. Head Neck 30(10):1339-43, 2008. e-Pub 2008. PMID: 18720521.
174. Gross ND, Boyle JO, Du B, Kekatpure VD, Lantowski A, Thaler HT, Weksler BB, Subbaramaiah K, Dannenberg AJ. Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma. Clin Cancer Res 13(19):5910-7, 2007. e-Pub 2007. PMID: 17908987.
175. Grosz AH, Sauer DA, Bliziotes MM, Cohen JI, Gross ND. Metastatic papillary thyroid carcinoma presenting as a long-standing calcified neck mass. Thyroid 17(8):799-800, 2007. e-Pub 2007. PMID: 17725440.
176. Ganly I, Gross ND, Patel SG, Bilsky MH, Shah JP, Kraus DH. Outcome of craniofacial resection in patients 70 years of age and older. Head Neck 29(2):89-94, 2007. e-Pub 2007. PMID: 16983689.
177. Balasingam V, Anderson GJ, ND G, Cheng CM, Noguchi A, Dogan A, McMenomey SO, Delashaw JB, Andersen PE. Anatomical analysis of transoral surgical approaches to the clivus. J Neurosurg 105(2):301-8, 2006. e-Pub 2006. PMID: 17219838.
178. Trune DR, Kempton JB, Gross ND. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res 212(1-2):22-32, 2006. e-Pub 2006. PMID: 16307853.
179. Gross ND, Boyle JO, Morrow JD, Williams MK, Moskowitz CS, Subbaramaiah K, Dannenberg AJ, Duffield-Lillico AJ. Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. Clin Cancer Res 11(16):6087-93, 2005. e-Pub 2005. PMID: 16115954.
180. ND G, Ellingson TW, Wax MK, Cohen JI, Andersen PE. Impact of Retropharyngeal Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Arch Otoloaryngol Head Neck Surg 130(2):169-73, 2004. e-Pub 2004.
181. Gross ND, Ellingson TW, Wax MK, Cohen JI, Andersen PE. Impact of retropharyngeal lymph node metastasis in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130(2):169-73, 2004. e-Pub 2004. PMID: 14967745.
182. ND G, Weissman JL, Veenker E, Cohen JI. The diagnostic utility of computed tomography for preoperative localization in surgery for hyperparathyroidism. Laryngoscope 114(2):227-31, 2004. e-Pub 2004. PMID: 14755195.
183. ND G, Cohen JI, Andersen PE. Outpatient endoscopic Zenker diverticulotomy. Laryngoscope 114(2):208-11, 2004. e-Pub 2004. PMID: 14755191.
184. ND G, Cohen JI, Andersen PE, Wax MK. 'Defatting' tracheotomy in morbidly obese patients. Laryngoscope 112(11):1940-4, 2002. e-Pub 2002. PMID: 12439159.
185. ND G, McInnes RJ, Hwang PH. Outpatient intravenous antibiotics for chronic rhinosinusitis. Laryngoscope 112(10):1758-61, 2002. e-Pub 2002. PMID: 12368610.
186. ND G, Kempton JB, Trune DR. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice. Laryngoscope 112(2):298-303, 2002. e-Pub 2002. PMID: 11889387.
187. ND G, Weissman JL, Talbot JM, Andersen PE, Wax MK, Cohen JI. MRI detection of cervical metastasis from differentiated thyroid carcinoma. Laryngoscope 111(11 Pt 1):1905-9, 2001. e-Pub 2001. PMID: 11801967.
188. Adams J, Heintz P, ND G, Andersen P, Everts E, Wax M, Cohen J. Acid/pepsin Promotion of Carcinogenesis in the Hamster Cheek Pouch. Arch Otolaryngol Head Neck Surg 126(3):405-9, 2000. e-Pub 2000.
189. Adams J, ND G, Riddle S, Andersen P, Cohen JI. An external landmark for the anterior commissure. Laryngoscope 109(7 Pt 1):1134-6, 1999. e-Pub 1999. PMID: 10401856.
190. Graville D, ND G, Andersen P, Everts E, Cohen J. The Long-term Indwelling Tracheoesophageal Prosthesis for Alaryngeal Voice Rehabilitation. Arch Otolaryngol Head Neck Surg 125(3):288-92, 1999. e-Pub 1999.
191. Gross ND, Wilson DJ, Dailey RA, Beckstead JH, Braziel RM. Nodular sclerosing Hodgkin disease with primary manifestation in the orbit. Ophthalmic Plast Reconstr Surg 14(3):169-73, 1998. e-Pub 1998. PMID: 9612806.
192. ND G, Wilson DJ, Dailey RA, Bectstead JH, Braziel RM. Nodular Sclerosing Hodgkin's Disease with Primary Manifestation in the Orbit. Opthal Plast Reconstr Surg 14(3):169-73, 1998. e-Pub 1998.
193. Gross ND, Wilson DJ, Dailey RA. Visual hallucinations after enucleation. Ophthalmic Plast Reconstr Surg 13(3):221-5, 1997. e-Pub 1997. PMID: 9306444.
194. ND G, Wilson DJ, Dailey RA. Visual Hallucinations after Enucleation. Opthal Plast Reconstr Surg 13(3):221-5, 1997. e-Pub 1997.
195. Auran JD, Hornblass A, Gross ND. Stevens-Johnson syndrome with associated nasolacrimal duct obstruction treated with dacryocystorhinostomy and Crawford silicone tube insertion. Ophthalmic Plast Reconstr Surg 6(1):60-3, 1990. e-Pub 1990. PMID: 2268602.
196. Gross ND, Hornblass A. Ligation of an arteriovenous malformation with the Heifetz clamp. Case report. Arch Ophthalmol 107(2):171, 1989. e-Pub 1989. PMID: 2916968.
197. Hornblass A, Gross ND. Lacrimal sac cyst. Ophthalmology 94(6):706-8, 1987. e-Pub 1987. PMID: 3627720.
198. Gross ND, Meyer RF. Enterobacter cloacae ulceration in a failed corneal graft: a case report. Br J Ophthalmol 69(7):542-4, 1985. e-Pub 1985. PMID: 3893527.
199. Li G, Zhang Y, Gang Huang ZG, Gross ND, Fang J, Chen X, Chen X, Hou L, Li P, Zhong Q. Laryngeal Carcinosarcoma: A Retrospective Study of 13 Cases. BioMed Res Int.

Invited Articles

1. Mucahy CF, Gross ND. Advances in Surgical Therapy for HPV-Associated Squamous Cell Carcinoma. Springer Nature. e-Pub 2022.
2. Burton EM, Amaria RN, Cascone T, Chalabi M, Gross ND, Mittendorf EA, Scolyer RA, Sharma P, Ascierto PA. Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge-December 1st-2nd, 2021. J Transl Med 20(1):271, 2022. e-Pub 2022. PMID: 35706041.
3. Contrera KJ, Gross ND, Patel MR, Mehta V, Ferris RL. Out of Committee: Outcomes Research and Evidence-Based Medicine | De-escalation of Adjuvant Treatment for HPV+ Oropharyngeal Cancer: TORS and ECOG 3311. Bulletin - AAO-HNS 40(10), 2021. e-Pub 2021.
4. Tam S, Gross ND. Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients. Curr Oncol Rep 21(9):82, 2019. e-Pub 2019. PMID: 31359288.
5. Ahmad FI, Su SY, Gross ND. The Role of Sentinel Lymph Node Biopsy in the Management of Cutaneous Malignancies. Facial Plast Surg Clin North Am 27(1):119-129, 2019. e-Pub 2019. PMID: 30420065.
6. Finegersh A, Holsinger FC, Gross ND, Orosco RK. Robotic Head and Neck Surgery. Surg Oncol Clin N Am 28(1):115-128, 2019. e-Pub 2019. PMID: 30414677.
7. Gross ND, Hanna EY. The Role of Surgery in the Management of Recurrent Oropharyngeal Cancer. Recent Results Cancer Res(206):197-205, 2017. e-Pub 2017. PMID: 27699540.
8. Sload R, Silver N, Jawad BA, Gross ND. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma. Curr Oncol Rep 18(9):53, 2016. e-Pub 2016. PMID: 27469262.
9. Sansoni ER, Gross ND. The Role of Transoral Robotic Surgery in the Management of Oropharyngeal Squamous Cell Carcinoma: a Current Review. Curr Oncol Rep 17(3):432, 2015. e-Pub 2015. PMID: 25687805.
10. Brickman D, Gross ND. Robotic Approaches to the Pharynx: Tonsil Cancer. Otolaryngol Clin North Am 47(3):359-72, 2014. e-Pub 2014. PMID: 24882794.
11. Clayburgh DR, Gross ND. Surgical Innovations. Otolaryngol Clin North Am 46(4):615-28, 2013. e-Pub 2013. PMID: 23910473.
12. Monroe MM, Gross ND. Evidence-based practice: management of the clinical node-negative neck in early-stage oral cavity squamous cell carcinoma. Otolaryngol Clin North Am 45(5):1181-93, 2012. e-Pub 2012. PMID: 22980692.
13. Gross ND, Wax MK. Unilateral and bilateral surgery for parathyroid disease. Otolaryngol Clin North Am 37(4):799-817, ix-x, 2004. e-Pub 2004. PMID: 15262517.

Review Articles

1. Oberhelman, N, Bruening, J, Jackson, RS, Van Abel, KM, Sumer, BD, Holsinger, F, Chan, JY, Gross, N, Clayburgh, DR, Andersen, PE, Li, RJ. Comparison of da Vinci Single Port vs Si Systems for Transoral Robotic-Assisted Surgery A Review With Technical Insights. JAMA Otolaryngology - Head and Neck Surgery 150(2):165-171, 2024. e-Pub 2024. PMID: 38127360.
2. Wilde, DC, Glaun, MD, Wong, MK, Gross, N. Neoadjuvant Approaches to Non-Melanoma Skin Cancer. Cancers 15(23), 2023. e-Pub 2023. PMID: 38067198.
3. Mulcahy, CF, Gross, N. Advances in Surgical Therapy for HPV-Associated Squamous Cell Carcinoma. Current Otorhinolaryngology Reports 10(4):475-482, 2022. e-Pub 2022.
4. Taku N, Wang L, Garden AS, Rosenthal DI, Gunn GB, Morrison WH, Fuller CD, Phan J, Reddy JP, Moreno AC, Spiotto MT, Chronowski G, Shah SJ, Mayo LL, Gross ND, Ferrarotto R, Zhu XR, Zhang X, Frank SJ. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy. Curr Treat Options Oncol 22(6):54, 2021. e-Pub 2021. PMID: 34086150.
5. Bravi, F, Lee, YC, Hashibe, M, Boffetta, P, Conway, DI, Ferraroni, M, La Vecchia, C, Edefonti, V, Agudo, A, Ahrens, W, Benhamou, S, Boccia, S, Brennan, P, Brenner, H, Cadoni, G, Canova, C, Chen, C, Chuang, SC, Curado, MP, Dal Maso, L, Daudt, AW, D'Souza, G, Fabianova, E, Fernandez, L, Franceschi, S, Garavello, W, Gillison, M, Gross, N, Hayes, RB, Healy, CM, Herrero, R, Holcatova, I, Kelsey, KT, Kjærheim, K, Koifman, R, Lagiou, P, Lazarus, P, Levi, F, Li, G, Lissowska, J, Luce, D, Macfarlane, GJ, Mates, D, Matsuo, K, McClean, M, Menezes, A, Menvielle, G, Morgenstern, H, Moyses, RA, Sturgis, EM. Lessons learned from the INHANCE consortium. Oral Diseases 27(1):73-93, 2021. e-Pub 2021. PMID: 32569410.
6. Meyer A, Gross ND, Teng M. AHNS Series: Do you know your guidelines? Perioperative antithrombotic management in head and neck surgery. Head Neck 40(1):182-191, 2018. e-Pub 2018. PMID: 29044795.
7. Cabanillas ME, Zafereo M, Williams MD, Ferrarotto R, Dadu R, Gross ND, Gunn GB, Skinner H, Cote G, Grosu HB, Iyer P, Busaidy NL. Recent Advances and Emerging Therapies in Anaplastic Thyroid Carcinoma. F1000Res 7, 2018. e-Pub 2018. PMID: 31583077.
8. Varley CD, Gross ND, Marx DP, Winthrop KL. Tuberculosis of the nasolacrimal duct. Ophthal Plast Reconstr Surg 27(5):e129-31, 2011. e-Pub 2011. PMID: 21242852.

Professional Educational Materials

1. Liu JC, Pagedar NA, GROSS ND. Oral Cavity Cancer: Professional Version, 2015.
2. GROSS ND. Contemporary Screening Techniques for Medullary Carcinoma of the Thyroid. American Academy of Otolaryngology Head and Neck Surgery, 2015.
3. GROSS ND. Nasopharyngeal Carcinoma. American Academy of Otolaryngology Head and Neck Surgery, 2015.
4. GROSS ND. Contemporary Adjunctive Cancer Therapy. American Academy of Otolaryngology Head and Neck Surgery, 2015.
5. GROSS ND. Academy U: Evidenced-based Approach to Treating Oral Cancer. American Academy of Otolaryngology - Head and Neck Surgery, 2012.
6. GROSS ND, Kraus DK. On-line Learning Series: Evidence-based Approach to Treating Oral Cavity Cancer. American Academy of Otolaryngology - Head and Neck Surgery, 2011.
7. GROSS ND. Patient of the Month Program: Pregnant Patient with a Thyroid Nodule. BC Decker, 2010.
8. GROSS ND. COOL Case Series: Non-Melanoma Cutaneous Malignancies. American Academy of Otolaryngology - Head and Neck Surgery, 2009.
9. GROSS ND. Rhinosinusitis: Intravenous antibiotics for chronic disease. Audio-Digest: Otolaryngology, 2002.
10. GROSS ND. Options for the Troubled Airway: Defatting Tracheostomy in Morbidly Obese Patients. Audio-Digest: Otolaryngology, 2002.
11. GROSS ND. Thoughts on Thyroid Disease: Cervical Metastasis. Audio-Digest: Otolaryngology, 2001.

Other Articles

1. Ferrarotto, R, Amit, M, Nagarajan, P, Rubin, ML, Yuan, Y, Bell, D, El-Naggar, AK, Johnson, JM, Morrison, WH, Rosenthal, D, Glisson, BS, Johnson, FM, Lu, C, Mott, FE, Esmaeli, B, Diaz Jr, EM, Gidley, PW, Goepfert, RP, Lewis, CM, Weber, RS, Wargo, J, Basu, S, Duan, F, Yadav, SS, Sharma, P, Allison, JP, Myers, JN, Gross, N Erratum. Clinical Cancer Research 28(8):1735, 2022. PMID: 35419587.
2. Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients >/=65 years old. Radiat Oncol 12(1):186, 2017. PMID: 29169353.
3. GROSS ND, Lee N, Wu A, Okuno S Treatment of Early (Stage I and II) Head and Neck Cancer: The Oral Cavity. UptoDate (online), 2016.
4. GROSS ND, Lee N, Wu A, Okuno S Treatment of Advanced (Stage III and IV) Head and Neck Cancer: The Oral Cavity. UptoDate (online), 2016.
5. GROSS ND, Monroe, M Skin Cancer: Squamous Cell Carcinoma. eMedicine Journal (online) 7(10), 2009.
6. Colevas AD, GROSS ND ASCO 2008 Annual Meeting Scientific Summary, Head and Neck Cancer Track. J Clin Oncol:70-76, 2008.

Editorials

1. Gross, N, Seiwert, T. Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care?. Cancer 130(6):846-847, 2024. PMID: 38236709.
2. Teckie S, Gross ND. The ORATOR Trials Have Spoken-Where Do We Go From Here?. JAMA Oncol 8(6):1-2, 2022. PMID: 35482361.
3. Gross ND, Weber RS. Has the Pendulum Swung Back to Surgery First for Oropharyngeal Cancer?. J Oncol Pract 11(12):1189-1191, 2016. PMID: 27858542.
4. Gross ND, Holsinger FC. Robotic Surgery of the Head and Neck. Otolaryngol Clin North Am 47(3):ix-x, 2014. PMID: 24882802.
5. Gross ND. Is Robotic Thyroid Surgery Worth the Learning Curve?. Otolaryngol Head Neck Surg 147(6):1047-8, 2012. PMID: 23012259.
6. Gross ND. Postoperative Hypocalcemia - The Difference a Definition Makes. Head Neck 32(3):283-4, 2010. PMID: 19691029.

Abstracts

1. Burtness B, Flamand Y, Quon H, Weinstein GS, Mehra R, Garcia JJ, Kim S, O’Malley Jr BW, Ozer E, Ikpeazu C, Koch WM, Gross ND, Bell R, Patel M, Lango MN, Morris LG, Smith R, Karakla D, Richmon JD, Holsinger FC, L Ferris AR. Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus– Initiated Oropharynx Cancer. Journal of Clinical Oncology, 2025. e-Pub 2025.
2. Mehra R, Flamand Y, Quon H, Garcia JJ, Weinstein GS, Duvvuri U, O'Malley BW, Ozer E, Thomas GR, Koch W, Gross ND, Bell RB, Saba NF, Lango M, Bayon R, Burtness B, Ferris RL. Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology 40(16), 2022. e-Pub 2022.
3. Lee A, Wang XA, Wang H, Moreno AC, Reddy J, Spiotto MT, Gunn GB, Rosenthal DI, Fuller CD, Morrison WH, Frank SJ, Ferrarotto R, Gross <, Goepfert RP, Gillenwater AM, Hessel AC, Su SY, Hanna EY, Garden AS, Phan J. Stereotactic Body Radiation Therapy (SBRT) Following Salvage Surgery for Previously Irradiated Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physics 112(5):e41, 2022. e-Pub 2022.
4. Barbon CE, Peterson CB, Dirba DD, Gunn GB, Frank SJ, Ferrarotto R, Johnson FM, Hessel AC, Goepfert RP, GROSS ND, Hutcheson KA. Comparison of Prospective, Longitudinal Swallowing Function after Primary Intensity-Modulated Proton Therapy (IMPT) or Transoral Robotic Surgery (TORS) for Oropharyngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology Biology Physics, 2020. e-Pub 2020.
5. Cabanillas ME, Dadu R, Ferrarotto R, Liu S, Fellman BM, Gross ND, Gule-Monroe M, Lu C, Grosu H, Williams MD, Duose DY, Mallampati S, Dervin S, Mckenna EF, Wang RJ, Zafereo M, Busaidy NL. Atezolizumab combinations with targeted therapy for anaplastic thyroid carcinoma (ATC). Journal of Clinical Oncology 38(15), 2020. e-Pub 2020.
6. Maniakas, A. Revolutionizing the therapeutic landscape of a deadly disease. 89th Annual Meeting of the American Thyroid Association, Chicago, Illinois, 2019. e-Pub 2019.
7. Sperling J. Prior cancers among patients newly diagnosed with anaplastic thyroid carcinoma: prevalence and impact on survival. 89th Annual Meeting of the American Thyroid Association, Chicago, Illinois, 2019. e-Pub 2019.
8. Hutcheson K, Zaveri J, Lewin J, Fuller C, Gunn B, Ferrarotto R, Yao C, GROSS ND. Evolution of postsurgical dysphagia after TORS for oropharyngeal cancer: A prospective registry analysis. American Head and Neck Society Annual Meeting, Austin, Texas, 2019. e-Pub 2019.
9. Cabanillas ME, Busaidy N, Dadu R, Ferrarotto R, GROSS ND, Guel-Monroe M, Lu C, Grosu H, Williams M, Zafereo ME. Combination vemurafenib (BRAF inhibitor)/cobimetinib (MEK inhibitor)/atezolizumab (anti-PDL1i) in BRAF-V600E mutated anaplastic thyroid cancer (ATC): initial safety and feasibility. Endocrine Society Meeting 2019, 2019. e-Pub 2019.
10. Wang J. Neoadjuvant Targeted Therapy Followed by Surgical Resection in BRAFV600E-mutated Anaplastic Thyroid Carcinoma. 88th Annual Meeting of the American Thyroid Association, 2018. e-Pub 2018.
11. Wang J. Facilitating rapid precision oncology in anaplastic thyroid cancer: Clinical implications of next generation sequencing (NGS) mutation testing and impact on survival. 2018 ASCO Annual Meeting, 2018. e-Pub 2018.
12. Chen M. Tracheal recurrences in HPV positive SCC. ASNR 56th Annual Meeting, 2018. e-Pub 2018.
13. Urdang Z. Evidence Supporting Free Head and Neck Cancer Screening. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, Chicago, Illinois, 2017. e-Pub 2017.
14. Desia N. Long-term Outcomes of Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck. American Head and Neck Society Annual Meeting, San Diego, California, 2017. e-Pub 2017.
15. Clayburgh D. A Randomized, Double-Blind, Placebo-Controlled Trial of Extended Course Corticosteroid For Post-Operative Pain Control Following Transoral Robotic Surgery (TORS). American Head and Neck Society - 9th International Conference on Head and Neck Cancer, Seattle, WA, 2016. e-Pub 2016.
16. Goepfert R. Complications and Hospital Length of Stay after Total Laryngectomy. American Head and Neck Society - 9th International Conference on Head and Neck Cancer, Seattle, WA, 2016. e-Pub 2016.
17. Heath H. Decreased Gastrostomy Tube Incidence and Weight Loss after Transoral Robotic Surgery for Early Oropharyngeal Squamous Cell Carcinoma. American Head and Neck Society - 9th International Conference on Head and Neck Cancer, Seattle, WA, 2016. e-Pub 2016.
18. Hutcheson K. Prospective Longitudinal Swallowing Outcomes after Chemotherapy and Split-Field IMRT for Advanced Stage T1-2 Oropharyngeal Cancer. American Society for Therapeutic Radiology and Oncology Annual Meeting, San Antonio, Texas, 2015. e-Pub 2015.
19. Rettig E. Prognostic Implication of Persistent HPV16 DNA Detection in Oral Rinses for HPV-positive Oropharyngeal Carcinoma. American Society of Clinical Oncology Annual Meeting, Chicago, Illinois, 2015. e-Pub 2015.
20. Gleysteen J. The Impact of Prophylactic External Carotid Artery Ligation on Postoperative Hemorrhage after Transoral Robotic Surgery (TORS) for Oropharyngeal Squamous Cell Carcinoma. American Head and Neck Society Annual Meeting, Boston, Massachusetts, 2015. e-Pub 2015.
21. Gleysteen J. Inconsistencies in the Application of Adjuvant Therapy after Transoral Robotic Surgery (TORS). 5th World Congress of IFHNOS and the American Head and Neck Society Annual Meeting, New York, New York, 2014. e-Pub 2014.
22. Moneta L. Death from Physician-Prescribed Lethal Medications in Head and Neck Cancer Patients: The Oregon Experience. 5th World Congress of IFHNOS and the American Head and Neck Society Annual Meeting, New York, New York, 2014. e-Pub 2014.
23. Milam B. The Detection of Methylated MicroRNAs in the Saliva of Head and Neck Cancer Patients for Tumor Diagnosis, Prognosis and Surveillance. 5th World Congress of IFHNOS and the American Head and Neck Society Annual Meeting, New York, New York, 2014. e-Pub 2014.
24. Ferris R. Phase I trial of intratumoral therapy using HF10, an oncolytic HSV-1, demonstrates safety in HSV+/HSV- patients with refractory and superficial cancers. American Society of Clinical Oncology Annual Meeting Chicago, Illinois, 2014. e-Pub 2014.
25. Bauman J. Erlotinib, dasatinib, erlotinib-dasatinib vs. placebo: A randomized, double-blind window study in operable head and neck squamous cell carcinoma. American Society of Clinical Oncology Annual Meeting, Chicago, Illinois, 2014. e-Pub 2014.
26. Gleysteen J. Human Papillomavirus among Veterans Treated for Oropharyngeal Squamous Cell Carcinoma. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, Orlando, Florida, 2014. e-Pub 2014.
27. Bauman J. Neoadjuvant erlotinib, erlotinib-sulindac, or placebo: A randomized, double-blind biomarker moduation study in operable head and neck squamous celll carcinoma. American Society of clinical Oncology Annual Meeting, Chicago, Illinois, 2013. e-Pub 2013.
28. Gildener-Leapman N. A phase I trial of intratumoral administration of HF10 in patients with refractory superficial cancer: Immune correlates of virus injection. American Society of Clinical Oncology Annual Meeting, Chicago, Illinois, 2013. e-Pub 2013.
29. D'Souza G. Oral HPV infection in HPV-positive oropharyngeal cancer cases and their spouses. American Society of Clinical Oncology Annual Meeting, Chicago, Illinois, 2013. e-Pub 2013.
30. Chia S. Surgeon experience and complications with transoral robotic surgery (TORS). American Head and Neck Society Annual Meeting, Orlando, Florida, 2013. e-Pub 2013.
31. Clayburgh D. Prospective Study of Venous Thromboembolism in Head and Neck Cancer. American Head and Neck Society Annual Meeting, Orlando, Florida, 2013. e-Pub 2013.
32. Patel S. The role of transoral robotic surgery in the work-up of the unknown primary head and neck squamous cell carcinoma. American Head and Neck Society Annual Meeting, Orlando, Florida, 2013. e-Pub 2013.
33. Litton T. Comparison of skin graft donor sites for fibula free flap skin paddle reconstruction. American Head and Neck Society Annual Meeting, Orlando, Florida, 2013. e-Pub 2013.
34. Park R. Nomogram predictive of 10-year cause-specific mortality in differentiated thyroid cancer. American Thyroid Association Annual Meeting, Montreal, Canada, 2012. e-Pub 2012.
35. Lindau R. Riedel's disease: a report of extensive disease requiring total laryngectomy. 8th International Conference on Head and Neck Cancer, Toronto, Canada, 2012. e-Pub 2012.
36. Pittman A. Stomal Recurrence: Salvage Surgery and Reconstruction. 8th International Conference on Head and Neck Cancer, Toronto, Canada, 2012. e-Pub 2012.
37. Lu SL. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinoma. 8th International Conference on Head and Neck Cancer, Toronto, Canada, 2012. e-Pub 2012.
38. Lindau R. Targeted biological chemotherapy agents and free flap survival. 8th International Conference on Head and Neck Cancer, Toronto, Canada, 2012. e-Pub 2012.
39. Clayburgh D. Prospective study of venous thromboembolism in head and neck cancer: interim analysis. 8th International Conference on Head and Neck Cancer, Toronto, Canada, 2012. e-Pub 2012.
40. Bornstein S. Overexpression of the PIK3CA oncogene drives head and neck cancer invasion and metastases. 8th International Conference on Head and Neck Cancer, Toronto, Canada, 2012. e-Pub 2012.
41. Rodriguez C. Overall Survival and Risk of Distant Failure among Malignant Salivary Gland Tumors in a Large Single-institution Registry Cohort. American Society of Clinical Oncology Annual Meeting, Chicago, Illinois, 2012. e-Pub 2012.
42. Ferris R. Phase I trial of intratumoral administration of HF10, a replication-competent herpes simplex virus type 1, in patients with refractory superficial cancer. American Society of Gene and Cell Therapy Annual Meeting, Philadelphia, Pennsylvania, 2012. e-Pub 2012.
43. Hooper J. HPV-positive oral squamous cell carcinoma is more common in the oropharynx of young male non-smokers. United States and Canadian Academy of Pathology Annual Meeting, Vancouver, B.C, 2012. e-Pub 2012.
44. Geltzeiler M. Regional control of head and neck melanoma with selective neck dissection. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, San Francisco, California, 2011. e-Pub 2011.
45. Clayburgh D. EGFR and IGF1R inhibition in head and neck cutaneous squamous cell carcinoma. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, San Francisco, California, 2011. e-Pub 2011.
46. Kiode J. Overexpression of CIP2A in head and neck cutaneous SCC. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, San Francisco, California, 2011. e-Pub 2011.
47. Monroe M. Acute invasive fungal rhinosinusitis: A 15 year experience with 28 patients. Combined Otolaryngology Spring Meeting Chicago, Illinois, 2011. e-Pub 2011.
48. Wester J. Airway reconstruction in Wegener's Laryngotracheal Stenosis. Triological Society Annual Meeting, Chicago, Illinois, 2011. e-Pub 2011.
49. Monroe M. Cancer Stem Cell Expression Patterns in Recurrent Head and Neck Squamous Cell Carcinoma. American Head and Neck Society Research Workshop on the Biology, Prevention and Treatment of Head & Neck Cancer, 2010. e-Pub 2010.
50. Thai L. Venous Thromboembolism in Head and Neck Cancer patients in surgery. American Head and Neck Society Research Workshop on the Biology, Prevention and Treatment of Head and Neck Cancer, Washington, D.C, 2010. e-Pub 2010.
51. Ng J. Orbital Reconstruction with Porous Polyethylene-coated titanium mesh and microvascular free flap following removal of malignant tumors. American Society of Ophthalmic Plastic, Orbital and Reconstructive Surgery Fall Symposium, 2010. e-Pub 2010.
52. Wang S. A prediction model for estimating the benefit of post-operative radiotherapy for oral cavity squamous cell carcinoma. American Society of Radiation Oncology Annual Meeting, San Diego, California, 2010. e-Pub 2010.
53. Miller M. False negative sentinel lymph node biopsy in head and neck melanoma. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, Boston, Masschusetts, 2010. e-Pub 2010.
54. Gregoire. An open-label, phase I/II dose-escalation trial investigating zalutumumab, a human monoclonal EGF receptor antibody, in combination with chemo-radiation as first line treatment of patients with locoregionally advanced squamous cell carcinoma of the head and neck. European Society of Therapeutic Radiology and Oncology, Barcelona, Spain, 2010. e-Pub 2010.
55. Varley C. Post-primary Tuberculosis of the Nasolacrimal Duct. Annual American Thoracic Society International Conference, New Orleans, Louisiana, 2010. e-Pub 2010.
56. Smith R. Management of Level VI in Patients with Papillar Thyroid Cancer. World Congress on Thyroid Cancer, Toronto, Canada, 2009. e-Pub 2009.
57. Salter K. Influence of Transforming Growth Factor Beta-1 Signaling on Papillary Thyroid Cancer with BRAF V600E Mutation. World Congress on Thyroid Cancer, Toronto, Canada, 2009. e-Pub 2009.
58. Park R. Nomogram Predictive of 10-Year Mortality in Differentiated Thyroid Cancer. World Congress on Thyroid Cancer Toronto, Canada, 2009. e-Pub 2009.
59. Salter K. Central nodal metastases in papillary thyroid carcinoma based on tumor histology and focality. American Head and Neck Society Annual Meeting, Phoenix, Arizona, 2009. e-Pub 2009.
60. Rossmiller S. The modified ileocolic free flap: A viable choice for reconstruction of total laryngopharyngectomy and total glossectomy. 7th International Conference on Head and Neck Cancer, San Francisco, California, 2008. e-Pub 2008.
61. Givi B. Outcome of patients treated surgically for lymph node metastases from cutaneous squamous cell carcinoma. 7th International Conference on Head and Neck Cancer, San Francisco, California, 2008. e-Pub 2008.
62. Wu V. Downregulation of LET-7 MicroRNA correlates with Ras Overexpression in head and neck squamous cell carcinoma. 7th International Conference on Head and Neck Cancer, San Francisco, California, 2008. e-Pub 2008.
63. Monroe M. Surgical Salvage for Recurrent Squamous Cell Carcinoma of the Oral Cavity. 7th International Conference on Head and Neck Cancer. San Francisco, California, 2008. e-Pub 2008.
64. Monroe M. Infected Tracheal Diverticulum. Alexander J. Schleuning, M.D. Memorial Competition, Oregon Academy of Otolaryngology Annual Meeting, Portland, Oregon, 2007. e-Pub 2007.
65. Wu V. Pectoralis Major Myocutaneous Flap Use in the Free Flap Era. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, Washington, D.C, 2007. e-Pub 2007.
66. McCarn K. Second Free Tissue Transfers in Head and Neck Reconstruction. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, Washington, D.C, 2007. e-Pub 2007.
67. Givi B. Outcome of Patients Treated Surgically for Lymph Node Metastatis from Cutaneous Squamous Cell Carcinoma. Oregon Chapter American College of Surgeons Annual Meeting, Lake Chelan, Washington, 2007. e-Pub 2007.
68. Givi B. Outcome of Patients Treated Surgically for Lymph Node Metastasis from Cutaneous Squamous Cell Carcinoma. Portland Surgical Society Annual Meeting, Portland, Oregon, 2007. e-Pub 2007.
69. McCarn K. Substernal Goiter requiring Median Sternotomy. Alexander J. Schleuning, M.D. Memorial Competition, Oregon Academy of Otolaryngology Annual Meeting, Portland, Oregon, 2007. e-Pub 2007.
70. Wax M. Composite Midface Soft Tissue Defects: The Utility of the Radial Rorearm Osteocutaneous Free Flap. 9th International Symposium of Facial Plastic Surgery, Las Vegas, Nevada, 2006. e-Pub 2006.
71. Smith D. Diffuse Idiopathic Skeletal Hyperostosis (DISH): A Surgical Disease?. American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, Orlando, Florida, 2003. e-Pub 2003.
72. Desyatnikova S. FNA Diagnosis of Follicular Neoplasm of the Thyroid: The OHSU Experience. Western Section Meeting, The Triological Society, San Francisco, California, 2000. e-Pub 2000.

Book Chapters

1. Wang, RY, Son, E, Fuller, C, Gross, N. Head and neck, 247-257, 2021.
2. Ahmad F, Su S, GROSS ND. Sentinel Lymph Node Biopsy in Skin Cancer Malignancies. In: Facial Plastic Surgery Clinics. Elsevier, 2019.
3. Cabanillas M, Weitzman S, Dadu R, Gansler T, Zafereo M. Thyroid Cancer. In: The American Cancer Society's Oncology in Practice: Clinical Management, 2018.
4. Brickman D, GROSS ND. Salivary Gland Cancer. In: American Cancer Society Textbook of Cancer. 3rd. John Wiley & Sons, Inc, 2017.
5. GROSS ND, Hanna EY. The Role of Surgery in the Management of Recurrent Oropharyngeal Cancer. In: HPV Infection in Head and Neck Cancer. 1st. Springer, 197-206, 2017.
6. Ferrell JK, Grossberg A, Mohamed AS, Fuller CD, Gold K, Hutcheson K, GROSS ND. Management of Early Stage (T1-2) Tonsillar Carcinoma. In: Oral, Head and Neck Oncology and Reconstructive Surgery. 1st. Elsevier, 2017.
7. Holliday EB, GROSS ND, Fuller CD, Rosenthal DI. Larynx Cancer. In: American Cancer Society Textbook of Cancer. 3rd. John Wiley & Sons, Inc, 2017.
8. Son EL, GROSS ND. Complications and Postoperative Care. In: Atlas of Robotic Surgery in Otolaryngology. 1st. Springer, 2017.
9. Son EL, Fuller CD, GROSS ND. Head and Neck Oncologic Emergencies. In: Oncologic Emergency Medicine. 1st. Springer, 169-78, 2016.
10. Holliday EB, GROSS ND, Fuller CD, Rosenthal DI. Larynx Cancer. In: American Cancer Society Textbook of Cancer. 2nd. John Wiley & Sons, Inc, 2015.
11. Brickman D, GROSS ND. Salivary Gland Cancer. In: American Cancer Society Textbook of Cancer. 2nd. John Wiley & Sons, Inc, 2015.
12. GROSS ND, Clayburgh DR, Kraus DK. Neoplasms of the Oral Cavity. In: Ballenger's Otorhinolaryngology Head and Neck Surgery. 18th. People's Medical Publishing House-USA, 2014.
13. Quintanilla-Dieck L, GROSS ND. Injury of Major Vessels. In: Thyroid Surgery: Managing Complications and Best Practice. 1st. Wiley-Blackwell, 161-7, 2013.
14. GROSS ND. Transoral Robotic Surgery (TORS). In: Atlas of Head and Neck Surgery. 1st. Elsevier, Inc, 2011.
15. Wax MW, Gross ND, Andersen PE. Carcinoma of the Salivary Glands. In: Head and Neck Cancer: An Evidence-Based Team Approach. Thieme Publishers, 2008.
16. GROSS ND, McMenomey SO. Aural complications of otitis media. In: Surgery of the Ear. 5th. BC Decker, Inc, 435-41, 2002.
17. Fraunfelder FT, GROSS ND. Pharmacological principles, delivery of topical ocular medication, and drugs which affect the pupil. In: Oxford Textbook of Ophthalmology. 2nd. Oxford University Press, 57-63, 1999.

Books (edited and written)

1. GROSS ND, Ed HF. Robotic Surgery in Otolaryngology. Elsevier Inc, 2014.
2. Gross ND, Ed CG. Atlas of Head and Neck Surgery. Ed(s) 2nd. Elsevier Inc.

Letters to the Editor

1. Schache, AG, Shaw, R, Winter, SC, Glasbey, J, Ganly, I, Batstone, M, Biel, JR, Nankivell, PC, Simon, C, Omar, O, Simoes, JF, Nepogodiev, D, Bhangu, A, Pinkney, TD, McGill, L, Perry, R, Hughes, T, Jackson, R, Glasbey, J, Ho, M, Nankivell, PC, Abbott, T, Adamina, M, Ademuyiwa, AO, Agarwal, A, AlAmeer, E, Alderson, D, Alakaloko, F, Albertsmeiers, M, Alser, O, Alshaar, M, Alshryda, S, Arnaud, AP, Augestad, KM, Ayasra, F, Azevedo, J, Bankhead-Kendall, BK, Barlow, E, Benson, RA, Colino, RB, Brar, A, Minaya-Bravo, A, Breen, KA, Bretherton, C, Buarque, IL, Burke, J, Caruana, EJ, Kowalski, LP, Vartanian, JG, Gross, N. Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery. BJS open 5, 2021.
2. Hutcheon K, GROSS ND, Fuller C. Radical Radiotherapy Should Remain the Standard of Care for Carcinoma Oropharynx-Reply. JAMA Otolaryngol Head Neck Surg 146: 505-506, 2020.